Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   osteoporosis
  

Disease ID 284
Disease osteoporosis
Definition
Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
Synonym
generalized osteoporosis
op - osteoporosis
osteoporoses
osteoporosis (disorder)
osteoporosis [disease/finding]
osteoporosis nos
osteoporosis nos (disorder)
osteoporosis, nos
osteoporosis, unspecified
osteoporosis, unspecified (disorder)
OMIM
DOID
UMLS
C0029456
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:195)
C0011847  |  diabetes  |  32
C0003873  |  rheumatoid arthritis  |  31
C0003864  |  arthritis  |  29
C0376358  |  prostate cancer  |  24
C0011849  |  diabetes mellitus  |  15
C0023895  |  liver disease  |  11
C0024117  |  chronic obstructive pulmonary disease  |  11
C0042870  |  vitamin d deficiency  |  10
C0011860  |  type 2 diabetes  |  10
C0042870  |  vitamin d defic  |  10
C0039730  |  thalassemia  |  10
C0021390  |  inflammatory bowel disease  |  10
C0020538  |  hypertension  |  10
C0006142  |  breast cancer  |  8
C0022821  |  kyphosis  |  8
C0021831  |  bowel disease  |  8
C0024115  |  pulmonary disease  |  8
C0600260  |  obstructive pulmonary disease  |  8
C0008312  |  primary biliary cirrhosis  |  7
C0022661  |  chronic kidney disease  |  7
C0042373  |  vascular disease  |  7
C0029442  |  osteomalacia  |  7
C0022658  |  kidney disease  |  6
C0020437  |  hypercalcemia  |  6
C0008312  |  biliary cirrhosis  |  6
C0004153  |  atherosclerosis  |  6
C0007222  |  cardiovascular disease  |  5
C0003125  |  anorexia nervosa  |  5
C0010674  |  cystic fibrosis  |  5
C0011570  |  depression  |  5
C0007570  |  celiac disease  |  5
C0020550  |  hyperthyroidism  |  4
C0036341  |  schizophrenia  |  4
C0029408  |  osteoarthritis  |  4
C0031090  |  periodontal disease  |  4
C0038013  |  ankylosing spondylitis  |  4
C0011854  |  type 1 diabetes  |  4
C0023895  |  liver diseases  |  4
C0010346  |  crohn's disease  |  4
C0035435  |  rheumatic disease  |  4
C0005940  |  bone disease  |  4
C0149521  |  chronic pancreatitis  |  4
C0020619  |  hypogonadism  |  4
C0018801  |  heart failure  |  4
C0028754  |  obesity  |  4
C1561644  |  chronic kidney disease (ckd)  |  3
C0029464  |  osteosclerosis  |  3
C0553662  |  juvenile idiopathic arthritis  |  3
C0026769  |  multiple sclerosis  |  3
C0024115  |  lung disease  |  3
C0036439  |  scoliosis  |  3
C0020502  |  hyperparathyroidism  |  3
C0030807  |  pemphigus  |  3
C0026764  |  myeloma  |  3
C0023890  |  cirrhosis  |  3
C0002871  |  anemia  |  3
C0035435  |  rheumatic diseases  |  3
C0021053  |  immune disease  |  2
C0948265  |  metabolic syndrome  |  2
C0038012  |  spondylitis  |  2
C0282193  |  iron overload  |  2
C0024141  |  systemic lupus erythematosus  |  2
C0020456  |  hyperglycemia  |  2
C0011860  |  type 2 diabetes mellitus  |  2
C0030305  |  pancreatitis  |  2
C0024899  |  mastocytosis  |  2
C0023449  |  acute lymphoblastic leukemia  |  2
C0036421  |  systemic sclerosis  |  2
C0039730  |  thalassaemia  |  2
C0023890  |  liver cirrhosis  |  2
C0040128  |  thyroid disease  |  2
C0023418  |  leukemia  |  2
C0027726  |  nephrotic syndrome  |  2
C0003872  |  psoriatic arthritis  |  2
C0030567  |  parkinson's disease  |  2
C0024623  |  gastric cancer  |  2
C0003467  |  anxiety  |  2
C0031099  |  periodontitis  |  2
C0497327  |  dementia  |  2
C0010481  |  cushing's syndrome  |  2
C0014544  |  epilepsy  |  2
C0030809  |  pemphigus vulgaris  |  2
C0221013  |  systemic mastocytosis  |  2
C0028754  |  adiposity  |  2
C0004096  |  bronchial asthma  |  2
C0026764  |  multiple myeloma  |  2
C0023448  |  lymphoblastic leukemia  |  2
C0034013  |  precocious puberty  |  1
C0014527  |  epidermolysis bullosa  |  1
C0005940  |  bone diseases  |  1
C0021390  |  inflammatory bowel diseases  |  1
C0029411  |  pachydermoperiostosis  |  1
C0458219  |  complex regional pain syndrome  |  1
C0024117  |  chronic obstructive pulmonary disease (copd)  |  1
C0040128  |  thyroid diseases  |  1
C0017178  |  gastrointestinal diseases  |  1
C0155502  |  benign paroxysmal positional vertigo  |  1
C0041408  |  turner syndrome  |  1
C0442874  |  neuropathy  |  1
C0022408  |  joint disease  |  1
C1261473  |  sarcoma  |  1
C0018995  |  hemochromatosis  |  1
C0017178  |  gastrointestinal disease  |  1
C0039263  |  takayasu disease  |  1
C0001418  |  adenocarcinoma  |  1
C0037944  |  spinal stenosis  |  1
C0027051  |  heart attack  |  1
C0037933  |  spinal disease  |  1
C0025322  |  early menopause  |  1
C0022104  |  irritable bowel  |  1
C0409974  |  lupus erythematosus  |  1
C0917715  |  hajdu-cheney syndrome  |  1
C0013264  |  duchenne muscular dystrophy  |  1
C0036202  |  sarcoidosis  |  1
C0033860  |  psoriasis  |  1
C0004134  |  ataxia  |  1
C0008370  |  biliary stasis  |  1
C0002453  |  amenorrhea  |  1
C0027051  |  myocardial infarct  |  1
C0022661  |  end-stage renal disease  |  1
C0029443  |  osteomyelitis  |  1
C0085096  |  peripheral vascular disease  |  1
C0026764  |  myelomatosis  |  1
C0014868  |  esophagitis  |  1
C0392525  |  nephrolithiasis  |  1
C0026850  |  muscular dystrophy  |  1
C0019069  |  haemophilia  |  1
C0022658  |  renal disease  |  1
C0020514  |  hyperprolactinaemia  |  1
C1565489  |  renal insufficiency  |  1
C0011860  |  non-insulin dependent diabetes  |  1
C0006277  |  bronchitis  |  1
C0026896  |  myasthenia gravis  |  1
C0002892  |  pernicious anemia  |  1
C0022735  |  klinefelter's syndrome  |  1
C0151740  |  intracranial hypertension  |  1
C0033953  |  sexual dysfunction  |  1
C0032463  |  polycythaemia vera  |  1
C0022661  |  chronic renal failure  |  1
C0042373  |  vascular problem  |  1
C0016063  |  osteitis fibrosa  |  1
C0011854  |  type 1 diabetes mellitus  |  1
C0162429  |  dietary deficiency  |  1
C0009782  |  connective tissue disease  |  1
C0007112  |  prostate adenocarcinoma  |  1
C0086543  |  cataract  |  1
C0206062  |  interstitial lung disease  |  1
C0003469  |  anxiety disorders  |  1
C0205944  |  epithelioid sarcoma  |  1
C0032461  |  polycythaemia  |  1
C0020443  |  hypercholesterolemia  |  1
C0019158  |  hepatitis  |  1
C0242379  |  lung cancer  |  1
C0022735  |  klinefelter syndrome  |  1
C0021831  |  intestinal diseases  |  1
C0035372  |  rett syndrome  |  1
C0011854  |  insulin dependent diabetes  |  1
C0042721  |  viral hepatitis  |  1
C0002395  |  alzheimer disease  |  1
C0037116  |  silicosis  |  1
C0524851  |  neurodegenerative disorders  |  1
C0031090  |  periodontal diseases  |  1
C0018802  |  congestive heart failure  |  1
C0035078  |  renal failure  |  1
C0027051  |  myocardial infarction  |  1
C0221002  |  primary hyperparathyroidism  |  1
C0010068  |  coronary artery disease  |  1
C0004096  |  asthma  |  1
C0242350  |  erectile dysfunction  |  1
C0032371  |  poliomyelitis  |  1
C0013595  |  eczema  |  1
C0003469  |  anxiety disorder  |  1
C0022408  |  joint diseases  |  1
C0022104  |  irritable bowel syndrome  |  1
C0020503  |  hyperparathyroidism secondary  |  1
C0037933  |  spinal diseases  |  1
C0020635  |  hypopituitarism  |  1
C0008373  |  cholesteatoma  |  1
C0154208  |  ovarian dysfunction  |  1
C0025202  |  melanoma  |  1
C0085207  |  maternal diabetes  |  1
C0032533  |  polymyalgia rheumatica  |  1
C0020676  |  hypothyroidism  |  1
C0016522  |  patent foramen ovale  |  1
C0029401  |  paget's disease  |  1
C1442839  |  hypervitaminosis d  |  1
C0013990  |  emphysema  |  1
C0271650  |  glucose intolerance  |  1
C0022658  |  nephropathy  |  1
C0032827  |  k deficiency  |  1
C0080178  |  spina bifida  |  1
C0021831  |  intestinal disease  |  1
C0022408  |  arthropathy  |  1
C0024523  |  malabsorption  |  1
C0029434  |  osteogenesis imperfecta  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:65)
IL6  |  3569  |  CTD_human
SOD2  |  6648  |  CTD_human
POMC  |  5443  |  CTD_human
TGFB1  |  7040  |  CTD_human
ENO1  |  2023  |  CTD_human
TPI1  |  7167  |  CTD_human
COL1A2  |  1278  |  CTD_human
COL1A1  |  1277  |  CTD_human
IL6R  |  3570  |  CTD_human
IDH2  |  3418  |  CTD_human
ACTG1  |  71  |  CTD_human
FGB  |  2244  |  CTD_human
FGA  |  2243  |  CTD_human
CYP19A1  |  1588  |  CTD_human
GPX1  |  2876  |  CTD_human
COLEC10  |  10584  |  GWASCAT
LRP5  |  4041  |  CTD_human;GHR
TNFRSF11B  |  4982  |  CTD_human
U2AF1  |  7307  |  CTD_human
VCL  |  7414  |  CTD_human
LTF  |  4057  |  CTD_human
P4HB  |  5034  |  CTD_human
RAB7B  |  338382  |  CTD_human
ANXA2  |  302  |  CTD_human
PRDX3  |  10935  |  CTD_human
FTCDNL1  |  348751  |  GWASCAT
PARK7  |  11315  |  CTD_human
ALDH7A1  |  501  |  GWASCAT
KL  |  9365  |  CTD_human
ATIC  |  471  |  CTD_human
GORAB  |  92344  |  CTD_human
PTH  |  5741  |  CTD_human
TPM4  |  7171  |  CTD_human
GAPDH  |  2597  |  CTD_human
OSBPL1A  |  114876  |  GWASCAT
CA2  |  760  |  CTD_human
TNFSF11  |  8600  |  CTD_human
WDR1  |  9948  |  CTD_human
VDR  |  7421  |  CTD_human
REN  |  5972  |  CTD_human
MECOM  |  2122  |  GWASCAT
RSU1  |  6251  |  CTD_human
OXCT1  |  5019  |  CTD_human
TUBA1B  |  10376  |  CTD_human
ADCY5  |  111  |  CTD_human
ZDHHC13  |  54503  |  CTD_human
PLEK  |  5341  |  CTD_human
PKM  |  5315  |  CTD_human
GSN  |  2934  |  CTD_human
CAP1  |  10487  |  CTD_human
WNT1  |  7471  |  UNIPROT
CCT2  |  10576  |  CTD_human
GPD2  |  2820  |  CTD_human
PSMA5  |  5686  |  CTD_human
PSMA2  |  5683  |  CTD_human
CALCR  |  799  |  CTD_human
PDLIM4  |  8572  |  CTD_human
MGLL  |  11343  |  CTD_human
TBC1D8  |  11138  |  GWASCAT
PNP  |  4860  |  CTD_human
ANTXR2  |  118429  |  CTD_human
RAP1A  |  5906  |  GWASCAT
DOK6  |  220164  |  GWASCAT
TLN1  |  7094  |  CTD_human
PGLS  |  25796  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:177)
79719  |  AAGAB  |  infer
55811  |  ADCY10  |  infer
197  |  AHSG  |  infer
9465  |  AKAP7  |  infer
501  |  ALDH7A1  |  infer
223  |  ALDH9A1  |  infer
367  |  AR  |  infer
50650  |  ARHGEF3  |  infer
481  |  ATP1B1  |  infer
552889  |  ATXN7L3B  |  infer
8707  |  B3GALT2  |  infer
632  |  BGLAP  |  infer
8548  |  BLZF1  |  infer
650  |  BMP2  |  infer
652  |  BMP4  |  infer
219557  |  C7orf62  |  infer
56934  |  CA10  |  infer
760  |  CA2  |  infer
767  |  CA8  |  infer
796  |  CALCA  |  infer
799  |  CALCR  |  infer
55832  |  CAND1  |  infer
846  |  CASR  |  infer
130940  |  CCDC148  |  infer
148870  |  CCDC27  |  infer
919  |  CD247  |  infer
952  |  CD38  |  infer
79577  |  CDC73  |  infer
1080  |  CFTR  |  infer
1121  |  CHM  |  infer
1186  |  CLCN7  |  infer
9685  |  CLINT1  |  infer
57472  |  CNOT6  |  infer
1268  |  CNR1  |  infer
1269  |  CNR2  |  infer
26047  |  CNTNAP2  |  infer
1277  |  COL1A1  |  infer
1278  |  COL1A2  |  infer
255631  |  COL24A1  |  infer
8804  |  CREG1  |  infer
10491  |  CRTAP  |  infer
1424  |  CRYGGP  |  infer
9646  |  CTR9  |  infer
1513  |  CTSK  |  infer
1588  |  CYP19A1  |  infer
1576  |  CYP3A4  |  infer
117159  |  DCD  |  infer
1756  |  DMD  |  infer
220164  |  DOK6  |  infer
1805  |  DPT  |  infer
112399  |  EGLN3  |  infer
647016  |  EIF2S2P7  |  infer
442720  |  EIF3IP1  |  infer
2099  |  ESR1  |  infer
2100  |  ESR2  |  infer
2153  |  F5  |  infer
51059  |  FAM135B  |  infer
149297  |  FAM78B  |  infer
26271  |  FBXO5  |  infer
2224  |  FDPS  |  infer
2247  |  FGF2  |  infer
2317  |  FLNB  |  infer
2322  |  FLT3  |  infer
2690  |  GHR  |  infer
2691  |  GHRH  |  infer
2692  |  GHRHR  |  infer
2693  |  GHSR  |  infer
10223  |  GPA33  |  infer
23432  |  GPR161  |  infer
3031  |  HADHAP1  |  infer
3099  |  HK2  |  infer
9957  |  HS3ST1  |  infer
3304  |  HSPA1B  |  infer
3305  |  HSPA1L  |  infer
22824  |  HSPA4L  |  infer
3557  |  IL1RN  |  infer
387597  |  ILDR2  |  infer
54928  |  IMPAD1  |  infer
9636  |  ISG15  |  infer
27133  |  KCNH5  |  infer
22920  |  KIFAP3  |  infer
64410  |  KLHL25  |  infer
4009  |  LMX1A  |  infer
53353  |  LRP1B  |  infer
4038  |  LRP4  |  infer
4041  |  LRP5  |  infer
440699  |  LRRC52  |  infer
84944  |  MAEL  |  infer
10982  |  MAPRE2  |  infer
4140  |  MARK3  |  infer
4259  |  MGST3  |  infer
9019  |  MPZL1  |  infer
351143  |  MRPL50P1  |  infer
4524  |  MTHFR  |  infer
29922  |  NME7  |  infer
9241  |  NOG  |  infer
4846  |  NOS3  |  infer
2494  |  NR5A2  |  infer
3084  |  NRG1  |  infer
390197  |  OR4D10  |  infer
114876  |  OSBPL1A  |  infer
5087  |  PBX1  |  infer
54510  |  PCDH18  |  infer
10130  |  PDIA6  |  infer
5241  |  PGR  |  infer
10464  |  PIBF1  |  infer
57480  |  PLEKHG1  |  infer
5351  |  PLOD1  |  infer
57645  |  POGK  |  infer
5451  |  POU2F1  |  infer
5468  |  PPARG  |  infer
100131033  |  PPIGP1  |  infer
5521  |  PPP2R2B  |  infer
5741  |  PTH  |  infer
5745  |  PTH1R  |  infer
348910  |  RAF1P1  |  infer
5906  |  RAP1A  |  infer
9693  |  RAPGEF2  |  infer
92241  |  RCSD1  |  infer
473  |  RERE  |  infer
100151679  |  RNU7-82P  |  infer
128467  |  RPL12P11  |  infer
100129670  |  RPL18P8  |  infer
645174  |  RPL21P46  |  infer
100271429  |  RPL21P99  |  infer
728567  |  RPL23AP48  |  infer
400055  |  RPL26P32  |  infer
100270887  |  RPL31P12  |  infer
342808  |  RPS2P6  |  infer
652411  |  RPSAP44  |  infer
860  |  RUNX2  |  infer
6258  |  RXRG  |  infer
57147  |  SCYL3  |  infer
6401  |  SELE  |  infer
6402  |  SELL  |  infer
6403  |  SELP  |  infer
6422  |  SFRP1  |  infer
375035  |  SFT2D2  |  infer
10560  |  SLC19A2  |  infer
55867  |  SLC22A11  |  infer
1836  |  SLC26A2  |  infer
53919  |  SLCO1C1  |  infer
6586  |  SLIT3  |  infer
50964  |  SOST  |  infer
55553  |  SOX6  |  infer
6678  |  SPARC  |  infer
6694  |  SPP2  |  infer
6711  |  SPTBN1  |  infer
29101  |  SSU72  |  infer
6772  |  STAT1  |  infer
11138  |  TBC1D8  |  infer
9095  |  TBX19  |  infer
10312  |  TCIRG1  |  infer
6997  |  TDGF1  |  infer
7012  |  TERC  |  infer
7040  |  TGFB1  |  infer
7056  |  THBD  |  infer
261726  |  TIPRL  |  infer
114795  |  TMEM132B  |  infer
7124  |  TNF  |  infer
8792  |  TNFRSF11A  |  infer
4982  |  TNFRSF11B  |  infer
7133  |  TNFRSF1B  |  infer
8600  |  TNFSF11  |  infer
7163  |  TPD52  |  infer
7371  |  UCK2  |  infer
7369  |  UMOD  |  infer
8615  |  USO1  |  infer
7421  |  VDR  |  infer
389136  |  VGLL3  |  infer
8876  |  VNN1  |  infer
157680  |  VPS13B  |  infer
11197  |  WIF1  |  infer
6375  |  XCL1  |  infer
9923  |  ZBTB40  |  infer
79670  |  ZCCHC6  |  infer
8187  |  ZNF239  |  infer
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:644)
2101  |  ESRRA  |  DISEASES
1856  |  DVL2  |  DISEASES
83930  |  STARD3NL  |  DISEASES
3097  |  HIVEP2  |  DISEASES
50865  |  HEBP1  |  DISEASES
64132  |  XYLT2  |  DISEASES
11215  |  AKAP11  |  DISEASES
5010  |  CLDN11  |  DISEASES
54432  |  YIPF1  |  DISEASES
7132  |  TNFRSF1A  |  DISEASES
55094  |  GPATCH1  |  DISEASES
9697  |  TRAM2  |  DISEASES
5351  |  PLOD1  |  DISEASES
3294  |  HSD17B2  |  DISEASES
2099  |  ESR1  |  DISEASES
28978  |  TMEM14A  |  DISEASES
23411  |  SIRT1  |  DISEASES
4282  |  MIF  |  DISEASES
5008  |  OSM  |  DISEASES
5594  |  MAPK1  |  DISEASES
3162  |  HMOX1  |  DISEASES
10278  |  EFS  |  DISEASES
4792  |  NFKBIA  |  DISEASES
1591  |  CYP24A1  |  DISEASES
5020  |  OXT  |  DISEASES
10857  |  PGRMC1  |  DISEASES
7076  |  TIMP1  |  DISEASES
479  |  ATP12A  |  DISEASES
54  |  ACP5  |  DISEASES
4313  |  MMP2  |  DISEASES
1445  |  CSK  |  DISEASES
6422  |  SFRP1  |  DISEASES
56729  |  RETN  |  DISEASES
7040  |  TGFB1  |  DISEASES
973  |  CD79A  |  DISEASES
6822  |  SULT2A1  |  DISEASES
1311  |  COMP  |  DISEASES
57817  |  HAMP  |  DISEASES
5444  |  PON1  |  DISEASES
51384  |  WNT16  |  DISEASES
10135  |  NAMPT  |  DISEASES
221830  |  TWISTNB  |  DISEASES
1749  |  DLX5  |  DISEASES
5054  |  SERPINE1  |  DISEASES
5919  |  RARRES2  |  DISEASES
1440  |  CSF3  |  DISEASES
6347  |  CCL2  |  DISEASES
1277  |  COL1A1  |  DISEASES
10014  |  HDAC5  |  DISEASES
786  |  CACNG1  |  DISEASES
7448  |  VTN  |  DISEASES
3381  |  IBSP  |  DISEASES
6688  |  SPI1  |  DISEASES
595  |  CCND1  |  DISEASES
1594  |  CYP27B1  |  DISEASES
4256  |  MGP  |  DISEASES
3458  |  IFNG  |  DISEASES
55907  |  CMAS  |  DISEASES
1432  |  MAPK14  |  DISEASES
2690  |  GHR  |  DISEASES
4015  |  LOX  |  DISEASES
6678  |  SPARC  |  DISEASES
3565  |  IL4  |  DISEASES
2908  |  NR3C1  |  DISEASES
3485  |  IGFBP2  |  DISEASES
3488  |  IGFBP5  |  DISEASES
2677  |  GGCX  |  DISEASES
7475  |  WNT6  |  DISEASES
7276  |  TTR  |  DISEASES
2691  |  GHRH  |  DISEASES
8074  |  FGF23  |  DISEASES
7043  |  TGFB3  |  DISEASES
1843  |  DUSP1  |  DISEASES
79646  |  PANK3  |  DISEASES
4488  |  MSX2  |  DISEASES
80129  |  CCDC170  |  DISEASES
8600  |  TNFSF11  |  DISEASES
4801  |  NFYB  |  DISEASES
3375  |  IAPP  |  DISEASES
847  |  CAT  |  DISEASES
92  |  ACVR2A  |  DISEASES
4656  |  MYOG  |  DISEASES
4852  |  NPY  |  DISEASES
1959  |  EGR2  |  DISEASES
5184  |  PEPD  |  DISEASES
6659  |  SOX4  |  DISEASES
2806  |  GOT2  |  DISEASES
1948  |  EFNB2  |  DISEASES
652  |  BMP4  |  DISEASES
6662  |  SOX9  |  DISEASES
51119  |  SBDS  |  DISEASES
57834  |  CYP4F11  |  DISEASES
2678  |  GGT1  |  DISEASES
5880  |  RAC2  |  DISEASES
22933  |  SIRT2  |  DISEASES
2658  |  GDF2  |  DISEASES
7166  |  TPH1  |  DISEASES
5908  |  RAP1B  |  DISEASES
3630  |  INS  |  DISEASES
84891  |  ZSCAN10  |  DISEASES
348  |  APOE  |  DISEASES
9210  |  BMP15  |  DISEASES
3727  |  JUND  |  DISEASES
529  |  ATP6V1E1  |  DISEASES
50617  |  ATP6V0A4  |  DISEASES
182  |  JAG1  |  DISEASES
1401  |  CRP  |  DISEASES
2167  |  FABP4  |  DISEASES
759  |  CA1  |  DISEASES
4853  |  NOTCH2  |  DISEASES
10468  |  FST  |  DISEASES
2012  |  EMP1  |  DISEASES
4907  |  NT5E  |  DISEASES
10220  |  GDF11  |  DISEASES
1593  |  CYP27A1  |  DISEASES
3569  |  IL6  |  DISEASES
3557  |  IL1RN  |  DISEASES
570  |  BAAT  |  DISEASES
11270  |  NRM  |  DISEASES
4322  |  MMP13  |  DISEASES
58472  |  SQRDL  |  DISEASES
1588  |  CYP19A1  |  DISEASES
10017  |  BCL2L10  |  DISEASES
23314  |  SATB2  |  DISEASES
2660  |  MSTN  |  DISEASES
3685  |  ITGAV  |  DISEASES
11213  |  IRAK3  |  DISEASES
4040  |  LRP6  |  DISEASES
3290  |  HSD11B1  |  DISEASES
217  |  ALDH2  |  DISEASES
79875  |  THSD4  |  DISEASES
3690  |  ITGB3  |  DISEASES
4092  |  SMAD7  |  DISEASES
4087  |  SMAD2  |  DISEASES
10959  |  TMED2  |  DISEASES
4969  |  OGN  |  DISEASES
495  |  ATP4A  |  DISEASES
7305  |  TYROBP  |  DISEASES
25939  |  SAMHD1  |  DISEASES
8455  |  ATRN  |  DISEASES
5595  |  MAPK3  |  DISEASES
23523  |  CABIN1  |  DISEASES
50507  |  NOX4  |  DISEASES
3552  |  IL1A  |  DISEASES
3553  |  IL1B  |  DISEASES
90  |  ACVR1  |  DISEASES
5775  |  PTPN4  |  DISEASES
56981  |  PRDM11  |  DISEASES
3574  |  IL7  |  DISEASES
3938  |  LCT  |  DISEASES
10874  |  NMU  |  DISEASES
2247  |  FGF2  |  DISEASES
3589  |  IL11  |  DISEASES
51665  |  ASB1  |  DISEASES
535  |  ATP6V0A1  |  DISEASES
6774  |  STAT3  |  DISEASES
5443  |  POMC  |  DISEASES
2355  |  FOSL2  |  DISEASES
3383  |  ICAM1  |  DISEASES
51176  |  LEF1  |  DISEASES
1950  |  EGF  |  DISEASES
56302  |  TRPV5  |  DISEASES
10371  |  SEMA3A  |  DISEASES
11059  |  WWP1  |  DISEASES
793  |  CALB1  |  DISEASES
10312  |  TCIRG1  |  DISEASES
51608  |  GET4  |  DISEASES
60314  |  C12orf10  |  DISEASES
196541  |  METTL21C  |  DISEASES
597  |  BCL2A1  |  DISEASES
3394  |  IRF8  |  DISEASES
7157  |  TP53  |  DISEASES
3487  |  IGFBP4  |  DISEASES
150094  |  SIK1  |  DISEASES
207  |  AKT1  |  DISEASES
5141  |  PDE4A  |  DISEASES
25888  |  ZNF473  |  DISEASES
113091  |  PTH2  |  DISEASES
126969  |  SLC44A3  |  DISEASES
1513  |  CTSK  |  DISEASES
5972  |  REN  |  DISEASES
805  |  CALM2  |  DISEASES
5746  |  PTH2R  |  DISEASES
6988  |  TCTA  |  DISEASES
3484  |  IGFBP1  |  DISEASES
2796  |  GNRH1  |  DISEASES
80005  |  DOCK5  |  DISEASES
1392  |  CRH  |  DISEASES
23196  |  FAM120A  |  DISEASES
4851  |  NOTCH1  |  DISEASES
133  |  ADM  |  DISEASES
128506  |  OCSTAMP  |  DISEASES
740  |  MRPL49  |  DISEASES
1489  |  CTF1  |  DISEASES
23657  |  SLC7A11  |  DISEASES
5741  |  PTH  |  DISEASES
1834  |  DSPP  |  DISEASES
3672  |  ITGA1  |  DISEASES
651  |  BMP3  |  DISEASES
9453  |  GGPS1  |  DISEASES
654  |  BMP6  |  DISEASES
56172  |  ANKH  |  DISEASES
89780  |  WNT3A  |  DISEASES
118611  |  C10orf90  |  DISEASES
11096  |  ADAMTS5  |  DISEASES
56934  |  CA10  |  DISEASES
27123  |  DKK2  |  DISEASES
760  |  CA2  |  DISEASES
761  |  CA3  |  DISEASES
245972  |  ATP6V0D2  |  DISEASES
7071  |  KLF10  |  DISEASES
9056  |  SLC7A7  |  DISEASES
23165  |  NUP205  |  DISEASES
1836  |  SLC26A2  |  DISEASES
1436  |  CSF1R  |  DISEASES
483  |  ATP1B3  |  DISEASES
11197  |  WIF1  |  DISEASES
5468  |  PPARG  |  DISEASES
3156  |  HMGCR  |  DISEASES
4681  |  NBL1  |  DISEASES
54361  |  WNT4  |  DISEASES
342096  |  GOLGA6A  |  DISEASES
1636  |  ACE  |  DISEASES
808  |  CALM3  |  DISEASES
29101  |  SSU72  |  DISEASES
7471  |  WNT1  |  DISEASES
246  |  ALOX15  |  DISEASES
4041  |  LRP5  |  DISEASES
148870  |  CCDC27  |  DISEASES
91461  |  PKDCC  |  DISEASES
2487  |  FRZB  |  DISEASES
27306  |  HPGDS  |  DISEASES
4286  |  MITF  |  DISEASES
6051  |  RNPEP  |  DISEASES
3549  |  IHH  |  DISEASES
213  |  ALB  |  DISEASES
200931  |  SLC51A  |  DISEASES
51705  |  EMCN  |  DISEASES
308  |  ANXA5  |  DISEASES
9607  |  CARTPT  |  DISEASES
1437  |  CSF2  |  DISEASES
1278  |  COL1A2  |  DISEASES
4982  |  TNFRSF11B  |  DISEASES
4846  |  NOS3  |  DISEASES
25879  |  DCAF13  |  DISEASES
81501  |  DCSTAMP  |  DISEASES
115825  |  WDFY2  |  DISEASES
7486  |  WRN  |  DISEASES
7253  |  TSHR  |  DISEASES
23588  |  KLHDC2  |  DISEASES
122042  |  RXFP2  |  DISEASES
4314  |  MMP3  |  DISEASES
9640  |  ZNF592  |  DISEASES
7480  |  WNT10B  |  DISEASES
50964  |  SOST  |  DISEASES
80150  |  ASRGL1  |  DISEASES
5617  |  PRL  |  DISEASES
79058  |  ASPSCR1  |  DISEASES
51523  |  CXXC5  |  DISEASES
598  |  BCL2L1  |  DISEASES
8313  |  AXIN2  |  DISEASES
3479  |  IGF1  |  DISEASES
121340  |  SP7  |  DISEASES
5734  |  PTGER4  |  DISEASES
3726  |  JUNB  |  DISEASES
3688  |  ITGB1  |  DISEASES
6869  |  TACR1  |  DISEASES
7804  |  LRP8  |  DISEASES
79412  |  KREMEN2  |  DISEASES
168544  |  ZNF467  |  DISEASES
25928  |  SOSTDC1  |  DISEASES
6726  |  SRP9  |  DISEASES
1051  |  CEBPB  |  DISEASES
118429  |  ANTXR2  |  DISEASES
2353  |  FOS  |  DISEASES
65084  |  TMEM135  |  DISEASES
56246  |  MRAP  |  DISEASES
23627  |  PRND  |  DISEASES
9451  |  EIF2AK3  |  DISEASES
3354  |  HTR1E  |  DISEASES
54205  |  CYCS  |  DISEASES
10238  |  DCAF7  |  DISEASES
2147  |  F2  |  DISEASES
81029  |  WNT5B  |  DISEASES
115111  |  SLC26A7  |  DISEASES
763  |  CA5A  |  DISEASES
27173  |  SLC39A1  |  DISEASES
4023  |  LPL  |  DISEASES
79974  |  CPED1  |  DISEASES
3265  |  HRAS  |  DISEASES
8061  |  FOSL1  |  DISEASES
392  |  ARHGAP1  |  DISEASES
836  |  CASP3  |  DISEASES
6578  |  SLCO2A1  |  DISEASES
5870  |  RAB6A  |  DISEASES
3952  |  LEP  |  DISEASES
2688  |  GH1  |  DISEASES
4281  |  MID1  |  DISEASES
10645  |  CAMKK2  |  DISEASES
3172  |  HNF4A  |  DISEASES
10657  |  KHDRBS1  |  DISEASES
354  |  KLK3  |  DISEASES
1831  |  TSC22D3  |  DISEASES
53832  |  IL20RA  |  DISEASES
8560  |  DEGS1  |  DISEASES
3291  |  HSD11B2  |  DISEASES
171483  |  FAM9B  |  DISEASES
27319  |  BHLHE22  |  DISEASES
56776  |  FMN2  |  DISEASES
63951  |  DMRTA1  |  DISEASES
54822  |  TRPM7  |  DISEASES
114876  |  OSBPL1A  |  DISEASES
2193  |  FARSA  |  DISEASES
7367  |  UGT2B17  |  DISEASES
8289  |  ARID1A  |  DISEASES
91445  |  RNF185  |  DISEASES
10938  |  EHD1  |  DISEASES
9370  |  ADIPOQ  |  DISEASES
6863  |  TAC1  |  DISEASES
6569  |  SLC34A1  |  DISEASES
3640  |  INSL3  |  DISEASES
9632  |  SEC24C  |  DISEASES
5745  |  PTH1R  |  DISEASES
4312  |  MMP1  |  DISEASES
55600  |  ITLN1  |  DISEASES
10491  |  CRTAP  |  DISEASES
7706  |  TRIM25  |  DISEASES
5021  |  OXTR  |  DISEASES
10586  |  MAB21L2  |  DISEASES
2932  |  GSK3B  |  DISEASES
55553  |  SOX6  |  DISEASES
5241  |  PGR  |  DISEASES
2300  |  FOXL1  |  DISEASES
55191  |  NADSYN1  |  DISEASES
4094  |  MAF  |  DISEASES
8204  |  NRIP1  |  DISEASES
633  |  BGN  |  DISEASES
1435  |  CSF1  |  DISEASES
4772  |  NFATC1  |  DISEASES
53833  |  IL20RB  |  DISEASES
9241  |  NOG  |  DISEASES
9735  |  KNTC1  |  DISEASES
83733  |  SLC25A18  |  DISEASES
256435  |  ST6GALNAC3  |  DISEASES
6667  |  SP1  |  DISEASES
51547  |  SIRT7  |  DISEASES
842  |  CASP9  |  DISEASES
3953  |  LEPR  |  DISEASES
131149  |  OTOL1  |  DISEASES
83999  |  KREMEN1  |  DISEASES
253190  |  SERHL2  |  DISEASES
796  |  CALCA  |  DISEASES
1675  |  CFD  |  DISEASES
23545  |  ATP6V0A2  |  DISEASES
2185  |  PTK2B  |  DISEASES
6546  |  SLC8A1  |  DISEASES
4088  |  SMAD3  |  DISEASES
2689  |  GH2  |  DISEASES
80864  |  EGFL8  |  DISEASES
91582  |  RPS19BP1  |  DISEASES
3043  |  HBB  |  DISEASES
5641  |  LGMN  |  DISEASES
2152  |  F3  |  DISEASES
3840  |  KPNA4  |  DISEASES
120227  |  CYP2R1  |  DISEASES
84068  |  SLC10A7  |  DISEASES
10076  |  PTPRU  |  DISEASES
51738  |  GHRL  |  DISEASES
51126  |  NAA20  |  DISEASES
8856  |  NR1I2  |  DISEASES
468  |  ATF4  |  DISEASES
4664  |  NAB1  |  DISEASES
51548  |  SIRT6  |  DISEASES
3932  |  LCK  |  DISEASES
7189  |  TRAF6  |  DISEASES
1576  |  CYP3A4  |  DISEASES
11142  |  PKIG  |  DISEASES
23462  |  HEY1  |  DISEASES
23436  |  CELA3B  |  DISEASES
6002  |  RGS12  |  DISEASES
63826  |  SRR  |  DISEASES
391  |  RHOG  |  DISEASES
2309  |  FOXO3  |  DISEASES
93  |  ACVR2B  |  DISEASES
80320  |  SP6  |  DISEASES
285268  |  ZNF621  |  DISEASES
4208  |  MEF2C  |  DISEASES
1758  |  DMP1  |  DISEASES
59277  |  NTN4  |  DISEASES
50650  |  ARHGEF3  |  DISEASES
5764  |  PTN  |  DISEASES
4089  |  SMAD4  |  DISEASES
84062  |  DTNBP1  |  DISEASES
51513  |  ETV7  |  DISEASES
1508  |  CTSB  |  DISEASES
79802  |  HHIPL2  |  DISEASES
388228  |  SBK1  |  DISEASES
92399  |  MRRF  |  DISEASES
2100  |  ESR2  |  DISEASES
257101  |  ZNF683  |  DISEASES
3605  |  IL17A  |  DISEASES
9962  |  SLC23A2  |  DISEASES
1499  |  CTNNB1  |  DISEASES
199953  |  TMEM201  |  DISEASES
766  |  CA7  |  DISEASES
1861  |  TOR1A  |  DISEASES
224  |  ALDH3A2  |  DISEASES
2879  |  GPX4  |  DISEASES
4205  |  MEF2A  |  DISEASES
6925  |  TCF4  |  DISEASES
79971  |  WLS  |  DISEASES
2335  |  FN1  |  DISEASES
7453  |  WARS  |  DISEASES
10656  |  KHDRBS3  |  DISEASES
5358  |  PLS3  |  DISEASES
140885  |  SIRPA  |  DISEASES
4047  |  LSS  |  DISEASES
5906  |  RAP1A  |  DISEASES
219844  |  HYLS1  |  DISEASES
10507  |  SEMA4D  |  DISEASES
284654  |  RSPO1  |  DISEASES
1953  |  MEGF6  |  DISEASES
2224  |  FDPS  |  DISEASES
84870  |  RSPO3  |  DISEASES
6711  |  SPTBN1  |  DISEASES
801  |  CALM1  |  DISEASES
4745  |  NELL1  |  DISEASES
54798  |  DCHS2  |  DISEASES
65989  |  DLK2  |  DISEASES
5079  |  PAX5  |  DISEASES
6714  |  SRC  |  DISEASES
4763  |  NF1  |  DISEASES
11091  |  WDR5  |  DISEASES
5336  |  PLCG2  |  DISEASES
55503  |  TRPV6  |  DISEASES
51606  |  ATP6V1H  |  DISEASES
799  |  CALCR  |  DISEASES
126014  |  OSCAR  |  DISEASES
10447  |  FAM3C  |  DISEASES
5599  |  MAPK8  |  DISEASES
1803  |  DPP4  |  DISEASES
25937  |  WWTR1  |  DISEASES
140803  |  TRPM6  |  DISEASES
56955  |  MEPE  |  DISEASES
2475  |  MTOR  |  DISEASES
133308  |  SLC9B2  |  DISEASES
171017  |  ZNF384  |  DISEASES
57154  |  SMURF1  |  DISEASES
58505  |  OSTC  |  DISEASES
8838  |  WISP3  |  DISEASES
9846  |  GAB2  |  DISEASES
4514  |  MT-CO3  |  DISEASES
7052  |  TGM2  |  DISEASES
961  |  CD47  |  DISEASES
22796  |  COG2  |  DISEASES
58480  |  RHOU  |  DISEASES
7042  |  TGFB2  |  DISEASES
90806  |  ANGEL2  |  DISEASES
5362  |  PLXNA2  |  DISEASES
6648  |  SOD2  |  DISEASES
7432  |  VIP  |  DISEASES
5788  |  PTPRC  |  DISEASES
5743  |  PTGS2  |  DISEASES
462  |  SERPINC1  |  DISEASES
356  |  FASLG  |  DISEASES
92344  |  GORAB  |  DISEASES
55811  |  ADCY10  |  DISEASES
2117  |  ETV3  |  DISEASES
10485  |  C1orf61  |  DISEASES
632  |  BGLAP  |  DISEASES
1520  |  CTSS  |  DISEASES
51177  |  PLEKHO1  |  DISEASES
1268  |  CNR1  |  DISEASES
515  |  ATP5F1  |  DISEASES
2316  |  FLNA  |  DISEASES
1586  |  CYP17A1  |  DISEASES
10451  |  VAV3  |  DISEASES
1629  |  DBT  |  DISEASES
1806  |  DPYD  |  DISEASES
115361  |  GBP4  |  DISEASES
2258  |  FGF13  |  DISEASES
959  |  CD40LG  |  DISEASES
3725  |  JUN  |  DISEASES
860  |  RUNX2  |  DISEASES
7422  |  VEGFA  |  DISEASES
1263  |  PLK3  |  DISEASES
83543  |  AIF1L  |  DISEASES
4318  |  MMP9  |  DISEASES
23413  |  NCS1  |  DISEASES
10269  |  ZMPSTE24  |  DISEASES
129685  |  TAF8  |  DISEASES
2022  |  ENG  |  DISEASES
54576  |  UGT1A8  |  DISEASES
127544  |  RNF19B  |  DISEASES
252995  |  FNDC5  |  DISEASES
2170  |  FABP3  |  DISEASES
1955  |  MEGF9  |  DISEASES
22943  |  DKK1  |  DISEASES
9550  |  ATP6V1G1  |  DISEASES
84676  |  TRIM63  |  DISEASES
240  |  ALOX5  |  DISEASES
1269  |  CNR2  |  DISEASES
2517  |  FUCA1  |  DISEASES
367  |  AR  |  DISEASES
55335  |  NIPSNAP3B  |  DISEASES
249  |  ALPL  |  DISEASES
177  |  AGER  |  DISEASES
8555  |  CDC14B  |  DISEASES
2159  |  F10  |  DISEASES
3376  |  IARS  |  DISEASES
9923  |  ZBTB40  |  DISEASES
6850  |  SYK  |  DISEASES
8660  |  IRS2  |  DISEASES
7133  |  TNFRSF1B  |  DISEASES
4524  |  MTHFR  |  DISEASES
55312  |  RFK  |  DISEASES
11138  |  TBC1D8  |  DISEASES
1471  |  CST3  |  DISEASES
765  |  CA6  |  DISEASES
5100  |  PCDH8  |  DISEASES
127262  |  TPRG1L  |  DISEASES
285440  |  CYP4V2  |  DISEASES
650  |  BMP2  |  DISEASES
55366  |  LGR4  |  DISEASES
5251  |  PHEX  |  DISEASES
9247  |  GCM2  |  DISEASES
51334  |  PRR16  |  DISEASES
2308  |  FOXO1  |  DISEASES
161003  |  STOML3  |  DISEASES
1543  |  CYP1A1  |  DISEASES
10631  |  POSTN  |  DISEASES
9365  |  KL  |  DISEASES
795  |  S100G  |  DISEASES
3456  |  IFNB1  |  DISEASES
6902  |  TBCA  |  DISEASES
6462  |  SHBG  |  DISEASES
1280  |  COL2A1  |  DISEASES
25975  |  EGFL6  |  DISEASES
2103  |  ESRRB  |  DISEASES
1045  |  CDX2  |  DISEASES
3486  |  IGFBP3  |  DISEASES
390874  |  ONECUT3  |  DISEASES
387733  |  IFITM5  |  DISEASES
23410  |  SIRT3  |  DISEASES
1186  |  CLCN7  |  DISEASES
6736  |  SRY  |  DISEASES
284266  |  SIGLEC15  |  DISEASES
8878  |  SQSTM1  |  DISEASES
9290  |  GPR55  |  DISEASES
338773  |  TMEM119  |  DISEASES
9130  |  FAM50A  |  DISEASES
57222  |  ERGIC1  |  DISEASES
6152  |  RPL24  |  DISEASES
60592  |  SCOC  |  DISEASES
5627  |  PROS1  |  DISEASES
5530  |  PPP3CA  |  DISEASES
79001  |  VKORC1  |  DISEASES
6696  |  SPP1  |  DISEASES
7227  |  TRPS1  |  DISEASES
655  |  BMP7  |  DISEASES
5744  |  PTHLH  |  DISEASES
2958  |  GTF2A2  |  DISEASES
3652  |  IPP  |  DISEASES
163223  |  ZNF676  |  DISEASES
5609  |  MAP2K7  |  DISEASES
90809  |  TMEM55B  |  DISEASES
594857  |  NPS  |  DISEASES
1394  |  CRHR1  |  DISEASES
4599  |  MX1  |  DISEASES
84709  |  MGARP  |  DISEASES
7442  |  TRPV1  |  DISEASES
81035  |  COLEC12  |  DISEASES
2492  |  FSHR  |  DISEASES
51270  |  TFDP3  |  DISEASES
728441  |  GGT2  |  DISEASES
7018  |  TF  |  DISEASES
2104  |  ESRRG  |  DISEASES
6295  |  SAG  |  DISEASES
64857  |  PLEKHG2  |  DISEASES
57703  |  CWC22  |  DISEASES
501  |  ALDH7A1  |  DISEASES
176  |  ACAN  |  DISEASES
2641  |  GCG  |  DISEASES
1385  |  CREB1  |  DISEASES
55577  |  NAGK  |  DISEASES
100506627  |  DCDC5  |  DISEASES
3481  |  IGF2  |  DISEASES
201456  |  FBXO15  |  DISEASES
197  |  AHSG  |  DISEASES
9658  |  ZNF516  |  DISEASES
4204  |  MECP2  |  DISEASES
8909  |  ENDOU  |  DISEASES
960  |  CD44  |  DISEASES
7124  |  TNF  |  DISEASES
3109  |  HLA-DMB  |  DISEASES
51562  |  MBIP  |  DISEASES
54503  |  ZDHHC13  |  DISEASES
387  |  RHOA  |  DISEASES
84290  |  CAPNS2  |  DISEASES
5334  |  PLCL1  |  DISEASES
4049  |  LTA  |  DISEASES
221981  |  THSD7A  |  DISEASES
23098  |  SARM1  |  DISEASES
54900  |  LAX1  |  DISEASES
57862  |  ZNF410  |  DISEASES
1589  |  CYP21A2  |  DISEASES
6424  |  SFRP4  |  DISEASES
3586  |  IL10  |  DISEASES
169200  |  TMEM64  |  DISEASES
3077  |  HFE  |  DISEASES
338376  |  IFNE  |  DISEASES
3712  |  IVD  |  DISEASES
80007  |  C10orf88  |  DISEASES
64343  |  AZI2  |  DISEASES
846  |  CASR  |  DISEASES
2317  |  FLNB  |  DISEASES
7511  |  XPNPEP1  |  DISEASES
2638  |  GC  |  DISEASES
1050  |  CEBPA  |  DISEASES
4147  |  MATN2  |  DISEASES
503542  |  SPRN  |  DISEASES
8322  |  FZD4  |  DISEASES
149685  |  ADIG  |  DISEASES
100129669  |  IZUMO3  |  DISEASES
3684  |  ITGAM  |  DISEASES
3250  |  HPR  |  DISEASES
5027  |  P2RX7  |  DISEASES
91  |  ACVR1B  |  DISEASES
246744  |  STH  |  DISEASES
11153  |  FICD  |  DISEASES
7421  |  VDR  |  DISEASES
8972  |  MGAM  |  DISEASES
84525  |  HOPX  |  DISEASES
53349  |  ZFYVE1  |  DISEASES
1734  |  DIO2  |  DISEASES
567  |  B2M  |  DISEASES
3949  |  LDLR  |  DISEASES
8792  |  TNFRSF11A  |  DISEASES
9294  |  S1PR2  |  DISEASES
55663  |  ZNF446  |  DISEASES
6625  |  SNRNP70  |  DISEASES
100885779  |  LINC-ROR  |  DISEASES
791114  |  PWRN1  |  DISEASES
107161157  |  YAM1  |  DISEASES
Locus(Waiting for update.)
Disease ID 284
Disease osteoporosis
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:1)
HP:0000939  |  Osteoporosis
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:146)
HP:0012531  |  Pain  |  34
HP:0001370  |  Rheumatoid arthritis  |  31
HP:0002953  |  Vertebral compression fractures  |  30
HP:0001369  |  Arthritis  |  29
HP:0012125  |  Prostate cancer  |  24
HP:0003418  |  Back pain  |  15
HP:0000819  |  Diabetes mellitus  |  15
HP:0002659  |  Increased tendency to fractures  |  14
HP:0002527  |  Falls  |  13
HP:0000938  |  Decreased bone mineral density  |  13
HP:0006510  |  Chronic obstructive pulmonary disease  |  11
HP:0100512  |  Vitamin D deficiency  |  10
HP:0000822  |  Hypertension  |  10
HP:0002808  |  Gibbus deformity  |  9
HP:0002757  |  Multiple fractures  |  8
HP:0003002  |  Breast carcinoma  |  8
HP:0012622  |  Chronic kidney disease  |  7
HP:0002749  |  Osteomalacia  |  7
HP:0002613  |  Biliary cirrhosis  |  6
HP:0003072  |  Hypercalcemia  |  6
HP:0003419  |  Low back pain  |  6
HP:0002653  |  Bone pain  |  6
HP:0002621  |  Atherosclerosis  |  6
HP:0002756  |  Pathologic fracture  |  5
HP:0002039  |  Anorexia  |  5
HP:0000716  |  Depression  |  5
HP:0002608  |  Celiac disease  |  5
HP:0001297  |  Cerebral vascular events  |  5
HP:0010885  |  Aseptic necrosis  |  5
HP:0000135  |  Hypogonadism  |  4
HP:0001635  |  Congestive heart failure  |  4
HP:0001513  |  Obesity  |  4
HP:0002902  |  Hyponatremia  |  4
HP:0002758  |  Osteoarthritis  |  4
HP:0000836  |  Overactive thyroid  |  4
HP:0100280  |  Morbus Crohn  |  4
HP:0100753  |  Schizophrenia  |  4
HP:0006280  |  Chronic pancreas inflammation  |  4
HP:0005681  |  Juvenile idiopathic arthritis  |  3
HP:0011001  |  Increased bone mineral density  |  3
HP:0002650  |  Scoliosis  |  3
HP:0001394  |  Hepatic cirrhosis  |  3
HP:0001903  |  Anemia  |  3
HP:0000843  |  Hyperparathyroidism  |  3
HP:0004934  |  Vascular calcification  |  3
HP:0011967  |  Hypocupremia  |  2
HP:0001909  |  Leukemia  |  2
HP:0000752  |  Hyperactive behavior  |  2
HP:0002725  |  Systemic lupus erythematosus  |  2
HP:0004950  |  Peripheral artery disease  |  2
HP:0000704  |  Pyorrhea  |  2
HP:0002960  |  Autoimmune condition  |  2
HP:0003074  |  High blood glucose  |  2
HP:0008443  |  Spinal deformities  |  2
HP:0001942  |  Metabolic acidosis  |  2
HP:0006721  |  Acute lymphocytic leukemia  |  2
HP:0000100  |  Nephrosis  |  2
HP:0002664  |  Neoplasia  |  2
HP:0012532  |  Chronic pain  |  2
HP:0001733  |  Pancreatic inflammation  |  2
HP:0000739  |  Anxiety  |  2
HP:0002099  |  Asthma  |  2
HP:0100495  |  Mastocytosis  |  2
HP:0000726  |  Dementia  |  2
HP:0003774  |  End-stage renal failure  |  2
HP:0012126  |  Gastric cancer  |  2
HP:0000820  |  Thyroid abnormality  |  2
HP:0001658  |  Myocardial infarction  |  2
HP:0000083  |  Renal insufficiency  |  2
HP:0006775  |  Multiple myeloma  |  2
HP:0002315  |  Headaches  |  1
HP:0000821  |  Underactive thyroid  |  1
HP:0002321  |  Vertigo  |  1
HP:0000964  |  Eczema  |  1
HP:0002240  |  Enlarged liver  |  1
HP:0002155  |  Increased triglycerides  |  1
HP:0100633  |  Inflammation of the esophagus  |  1
HP:0000826  |  Precocious puberty  |  1
HP:0100242  |  Sarcoma  |  1
HP:0000833  |  Glucose intolerance  |  1
HP:0000924  |  Abnormality of the skeletal system  |  1
HP:0030833  |  Neck pain  |  1
HP:0001371  |  Flexion contractures of joints  |  1
HP:0000870  |  Hyperprolactinemia  |  1
HP:0008200  |  Primary hyperparathyroidism  |  1
HP:0002097  |  Pulmonary emphysema  |  1
HP:0003765  |  Psoriasis  |  1
HP:0003416  |  Spinal canal stenosis  |  1
HP:0001907  |  Thromboembolic disease  |  1
HP:0002150  |  Hypercalcinuria  |  1
HP:0004626  |  Lumbar scoliosis  |  1
HP:0001677  |  Coronary artery disease  |  1
HP:0003124  |  Elevated serum cholesterol  |  1
HP:0006562  |  Viral hepatitis  |  1
HP:0001824  |  Weight loss  |  1
HP:0000124  |  Renal tubular defect  |  1
HP:0002812  |  Coxa vara  |  1
HP:0002948  |  Fusion of vertebral bodies  |  1
HP:0002754  |  Bone infection  |  1
HP:0040075  |  Hypopituitarism  |  1
HP:0000969  |  Dropsy  |  1
HP:0002797  |  Increased bone resorption  |  1
HP:0006528  |  Chronic lung disease  |  1
HP:0100295  |  Muscle fibre atrophy  |  1
HP:0000802  |  Erectile dysfunction  |  1
HP:0012418  |  Low blood oxygen level  |  1
HP:0009797  |  Cholesteatoma  |  1
HP:0010834  |  Trophic changes  |  1
HP:0100805  |  Precocious menopause  |  1
HP:0004619  |  Lumbar kyphoscoliosis  |  1
HP:0005952  |  Decreased lung function  |  1
HP:0009800  |  gestational diabetes  |  1
HP:0002024  |  Intestinal malabsorption  |  1
HP:0002153  |  Elevated serum potassium levels  |  1
HP:0000787  |  Renal calculi  |  1
HP:0002148  |  Hypophosphataemia  |  1
HP:0002516  |  Intracranial pressure elevation  |  1
HP:0002751  |  Kyphoscoliosis  |  1
HP:0002511  |  Late-onset form of familial Alzheimer disease  |  1
HP:0002414  |  Spina bifida  |  1
HP:0004610  |  Narrow lumbar spinal canal  |  1
HP:0000230  |  Inflamed gums  |  1
HP:0003040  |  Arthropathy  |  1
HP:0002861  |  Melanoma  |  1
HP:0003560  |  Muscular dystrophy  |  1
HP:0001941  |  acidemia  |  1
HP:0000141  |  Abnormal absence of menstruation  |  1
HP:0000518  |  Cataract  |  1
HP:0000026  |  Decreased function of male gonad  |  1
HP:0012115  |  Liver inflammation  |  1
HP:0001251  |  Ataxia  |  1
HP:0001655  |  Patent foramen ovale  |  1
HP:0012387  |  Bronchitis  |  1
HP:0012393  |  Allergy  |  1
HP:0012378  |  Fatigue  |  1
HP:0004349  |  Reduced bone mineral density  |  1
HP:0002018  |  Nausea  |  1
HP:0002611  |  Cholestatic liver disease  |  1
HP:0000112  |  Nephropathy  |  1
HP:0012533  |  Allodynia  |  1
HP:0006530  |  Interstitial lung disease  |  1
HP:0002094  |  Dyspnea  |  1
HP:0002942  |  Thoracic kyphosis  |  1
HP:0005086  |  Knee osteoarthritis  |  1
HP:0003473  |  Fatigable weakness  |  1
HP:0012735  |  Coughing  |  1
Disease ID 284
Disease osteoporosis
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:20)
C0030193  |  pain  |  34
C1390474  |  bone fragility  |  14
C0042870  |  vitamin d deficiency  |  10
C0006142  |  breast cancer  |  8
C0022821  |  kyphosis  |  8
C0151825  |  bone pain  |  6
C0007570  |  celiac disease  |  5
C0023895  |  liver diseases  |  4
C0038013  |  ankylosing spondylitis  |  4
C0029464  |  osteosclerosis  |  3
C0020502  |  hyperparathyroidism  |  3
C0599750  |  hormone deficiency  |  2
C1955566  |  intravenous bisphosphonates  |  2
C0150055  |  chronic pain  |  2
C0026764  |  multiple myeloma  |  2
C0184567  |  acute pain  |  1
C0427008  |  stiffness  |  1
C0017178  |  gastrointestinal diseases  |  1
C0236075  |  menopausal symptoms  |  1
C1384666  |  hearing loss  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:162)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs1038304216469262099ESR1umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.1542630432011CCDC1706151612040AG
rs103830421646926182JAG1umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.0002714422011CCDC1706151612040AG
rs1038304216469264038LRP4umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.0031813582011CCDC1706151612040AG
rs104162652443050551384WNT16umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0005428842015GPATCH11933114394AG
rs104162652443050584870RSPO3umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015GPATCH11933114394AG
rs10416265244305056711SPTBN1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0026384742015GPATCH11933114394AG
rs104162652443050522943DKK1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0013572092015GPATCH11933114394AG
rs10416265244305052099ESR1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.1542630432015GPATCH11933114394AG
rs104162652443050555094GPATCH1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015GPATCH11933114394AG
rs104162652443050565084TMEM135umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015GPATCH11933114394AG
rs1048707617903296219557C7orf62umls:C0029456GAD[The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.]0.0023670322007NA789348607TC
rs1049203617903295114795TMEM132Bumls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007NA12125719508TC
rs104926531790329510464PIBF1umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007PIBF11372969927GA
rs104931481790329522824HSPA4Lumls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007HSPA4L4127830446TC
rs10494675179032958707B3GALT2umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007B3GALT2;CDC731193181743TC
rs104946751790329579577CDC73umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007B3GALT2;CDC731193181743TC
rs10499182179032969465AKAP7umls:C0029456GAD[The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.]0.0023670322007AKAP76131172269CT
rs105042161790329654928IMPAD1umls:C0029456GAD[The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.]0.0023670322007NA857068911GA
rs1050633017903296117159DCDumls:C0029456GAD[The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.]0.0023670322007NA1254697497AT
rs105065321790329611197WIF1umls:C0029456GAD[The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.]0.0023670322007WIF11265111882CT
rs105065501790329655832CAND1umls:C0029456GAD[The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.]0.0023670322007LOC1053698121267451682CA
rs1050669817903295552889ATXN7L3Bumls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007NA1274651637TC
rs10515754179032969685CLINT1umls:C0029456GAD[The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.]0.0023670322007CLINT15157806530TC
rs10516056179032966586SLIT3umls:C0029456GAD[The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.]0.0023670322007SLIT35169041532CT
rs105161431790329657472CNOT6umls:C0029456GAD[The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.]0.0023670322007CNOT65180553302TA
rs10516264179032969957HS3ST1umls:C0029456GAD[The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.]0.0023670322007LOC105374494413032521CT
rs1051629317903296952CD38umls:C0029456GAD[The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.]0.0023670322007CD38415848487GA
rs1056836189774671545CYP1B1umls:C0029456BeFreeOur data suggest that through its effect on the rate of estrogen catabolism, the Val432Leu polymorphism of the CYP1B1 gene may represent as a possible genetic risk factor for osteoporosis in American women.0.0002714422009CYP1B1238071060GC
rs11061841790329510130PDIA6umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007PDIA6210823401TC
rs11859916220872927369UMODumls:C0029456GAD[Our study implicated HK2, UMOD, MIR873 and MIR876, as pleiotropic genes underlying variation of both FNGPs and ALM, thus suggesting their important functional roles in co-regulating both FNGPs and ALM.]0.0023670322011UMOD1620339909GA
rs118985052443050551384WNT16umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0005428842015SPTBN1254457420AG
rs118985052443050565084TMEM135umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015SPTBN1254457420AG
rs11898505244305052099ESR1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.1542630432015SPTBN1254457420AG
rs118985052443050555094GPATCH1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015SPTBN1254457420AG
rs118985052443050584870RSPO3umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015SPTBN1254457420AG
rs118985052443050522943DKK1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0013572092015SPTBN1254457420AG
rs11898505244305056711SPTBN1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0026384742015SPTBN1254457420AG
rs12151790205489446694SPP2umls:C0029456GAD[An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility Loci for osteoporosis-related traits.]0.0023670322010LOC1053739332234302083GA
rs12218235224297439BEST1umls:C0029456BeFreeAnd the rs12218 was found to be associated with plasma TG, HDL-C, LDL-C, and BMD levels in osteoporosis patients (P<0.05).0.0076003722013SAA11118269774TC
rs1267369223303384221981THSD7Aumls:C0029456BeFreeWe previously reported 2 osteoporosis-susceptibility genes--formiminotransferase N-terminal sub-domain containing gene (FONG) and thrombospondin, type 1, domain-containing 7A (THSD7A)--in which we identified two common single-nucleotide polymorphisms, rs7605378 (FONG) and rs12673692 (THSD7A).0.0035386762013THSD7A711528903GA
rs1318240220072603501ALDH7A1umls:C0029456GWASCATGenome-wide association study identifies ALDH7A1 as a novel susceptibility gene for osteoporosis.0.1226384742010ALDH7A15126582456AG
rs13756151790329553353LRP1Bumls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007LRP1B2142041516CT
rs150727417903296255631COL24A1umls:C0029456GAD[The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.]0.0023670322007NA186193766TA
rs156116417903295389136VGLL3umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007NA387076876GA
rs16063211790329551059FAM135Bumls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007FAM135B8138343962AG
rs1718455720548944220164DOK6umls:C0029456GAD[An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility Loci for osteoporosis-related traits.]0.1223670322010DOK61869475621TA
rs1718455720548944220164DOK6umls:C0029456GWASCATAn integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility Loci for osteoporosis-related traits.0.1223670322010DOK61869475621TA
rs17651228688023552IL1Aumls:C0029456BeFreeOur results of the association of IL-1α gene single nucleotide polymorphisms (SNPs) rs2071375 (+12534G>A) and rs17651 (+4845G>T) with osteoporotic features indicate its role in pathogenesis of osteoporosis.0.0038101182012NANANANANA
rs1800629157979577124TNFumls:C0029456BeFreeWe evaluated the association between a G-308A polymorphism (rs1800629) at the TNFA locus and osteoporosis phenotypes in 4306 older women participating in the Study of Osteoporotic Fractures.0.0182600072005TNF631575254GA
rs1800796195067921917EEF1A2umls:C0029456BeFreeAfter adjusting for age, the IL6 -634G > C (rs1800796) allele showed association with osteoporosis (odds ratio (OR) for CC + CG = 2.51, p = 0.0047)), independent of statin use or smoking status.0.0002714422010IL6;LOC541472722726627GC
rs1801133177127174524MTHFRumls:C0029456BeFreeThe C677T (rs1801133) polymorphism of MTHFR (methylenetetrahydrofolate reductase) has been associated with the risk of cardiovascular events, and also with osteoporosis in some studies.0.0223653112007MTHFR111796321GA
rs180172517374704846CASRumls:C0029456BeFreeAn alanine (A) to serine (S) polymorphism at codon 986 (A986S) of the CASR gene has been associated with higher calcium and osteoporosis; the association with coronary artery disease (CAD) has not been studied.0.0019000932007CASR3122284910GT
rs180172512574201846CASRumls:C0029456BeFreeThese results are in contrast to those in young or premenopausal women, and they provide no support for an important role for the CASR A986S polymorphism in osteoporosis.0.0019000932003CASR3122284910GT
rs18581141790329554510PCDH18umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007NA4137814564AG
rs188383218097708958CD40umls:C0029456BeFreeWomen with the TT genotype in rs1883832 SNP affecting to Kozak consensus sequence of CD40 gene had lower BMD at FN and at LS sites and increased risk of osteopenia or osteoporosis.0.0029957922008CD402046118343TC
rs194321217903295284274SMIM21umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007NA1875730496CT
rs20623752054894410584COLEC10umls:C0029456GWASCATAn integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility Loci for osteoporosis-related traits.0.122010COLEC108118965553GC
rs2062375205489444982TNFRSF11Bumls:C0029456GAD[A two-stage meta-analysis of GWAS from 7,633 Caucasian women and 3,657 men, revealed three novel loci associated with osteoporosis-related traits, including chromosome 1p13.2 (RAP1A, p = 3.6x10(-8)), 2q11.2 (TBC1D8), and 18q11.2 (OSBPL1A), and confirmed a previously reported region near TNFRSF11B/OPG gene.]0.1698543422010COLEC108118965553GC
rs2071375228688023552IL1Aumls:C0029456BeFreeOur results of the association of IL-1α gene single nucleotide polymorphisms (SNPs) rs2071375 (+12534G>A) and rs17651 (+4845G>T) with osteoporotic features indicate its role in pathogenesis of osteoporosis.0.0038101182012IL1A2112777861CT
rs21015521790329527133KCNH5umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007KCNH51462726230TC
rs22146811790329626047CNTNAP2umls:C0029456GAD[The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.]0.0023670322007CNTNAP27148005600AG
rs2223713179032951121CHMumls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007NAX86110417AC
rs225147117903296130940CCDC148umls:C0029456GAD[The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.]0.0023670322007CCDC1482158391218CT
rs227306121646926182JAG1umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.0002714422011JAG12010658895GA
rs2273061216469262099ESR1umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.1542630432011JAG12010658895GA
rs2273061216469264038LRP4umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.0031813582011JAG12010658895GA
rs22787292054894411138TBC1D8umls:C0029456GWASCATA two-stage meta-analysis of GWAS from 7,633 Caucasian women and 3,657 men, revealed three novel loci associated with osteoporosis-related traits, including chromosome 1p13.2 (RAP1A, p = 3.6x10(-8)), 2q11.2 (TBC1D8), and 18q11.2 (OSBPL1A), and confirmed a previously reported region near TNFRSF11B/OPG gene.0.1226384742010TBC1D82101052395GA
rs22787292054894411138TBC1D8umls:C0029456GAD[A two-stage meta-analysis of GWAS from 7,633 Caucasian women and 3,657 men, revealed three novel loci associated with osteoporosis-related traits, including chromosome 1p13.2 (RAP1A, p = 3.6x10(-8)), 2q11.2 (TBC1D8), and 18q11.2 (OSBPL1A), and confirmed a previously reported region near TNFRSF11B/OPG gene.]0.1226384742010TBC1D82101052395GA
rs2297480186871672224FDPSumls:C0029456GAD[Danish postmenopausal women with osteoporosis bearing the homozygous CC genotype for rs2297480 FDPS polymorphism showed a decreased response of bone turnover markers to amino-bisphosphonate therapy, when compared to the heterozygous AC and to the homozygous AA genotypes.]0.0029099162008FDPS;PKLR1155309691TG
rs2306033216469264038LRP4umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.0031813582011LRP41146875895GA
rs2306033216469262099ESR1umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.1542630432011LRP41146875895GA
rs230603321646926182JAG1umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.0002714422011LRP41146875895GA
rs23364341790329611197WIF1umls:C0029456GAD[The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.]0.0023670322007NA1265125486TG
rs2424513179032957056THBDumls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007NA2023065387GA
rs2908007244305056711SPTBN1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0026384742015NA7121322110AG
rs29080072443050522943DKK1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0013572092015NA7121322110AG
rs29080072443050565084TMEM135umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015NA7121322110AG
rs29080072443050555094GPATCH1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015NA7121322110AG
rs2908007244305052099ESR1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.1542630432015NA7121322110AG
rs29080072443050584870RSPO3umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015NA7121322110AG
rs29080072443050551384WNT16umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0005428842015NA7121322110AG
rs29825522443050584870RSPO3umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015ESR16151738428GA
rs29825522443050522943DKK1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0013572092015ESR16151738428GA
rs2982552244305052099ESR1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.1542630432015ESR16151738428GA
rs29825522443050555094GPATCH1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015ESR16151738428GA
rs2982552244305056711SPTBN1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0026384742015ESR16151738428GA
rs29825522443050565084TMEM135umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015ESR16151738428GA
rs29825522443050551384WNT16umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0005428842015ESR16151738428GA
rs30203312443050551384WNT16umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0005428842015NA6151687645CT
rs3020331244305056711SPTBN1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0026384742015NA6151687645CT
rs30203312443050584870RSPO3umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015NA6151687645CT
rs30203312443050555094GPATCH1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015NA6151687645CT
rs30203312443050565084TMEM135umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015NA6151687645CT
rs30203312443050522943DKK1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0013572092015NA6151687645CT
rs3020331244305052099ESR1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.1542630432015NA6151687645CT
rs3130340216469262099ESR1umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.1542630432011LOC101929163632276850TC
rs313034021646926182JAG1umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.0002714422011LOC101929163632276850TC
rs3130340216469264038LRP4umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.0031813582011LOC101929163632276850TC
rs324702179032958615USO1umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007NA475816637CG
rs324735179032958615USO1umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007USO1475783861AT
rs3407071790329551059FAM135Bumls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007FAM135B8138367721TC
rs371388179032955521PPP2R2Bumls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007PPP2R2B5146682504AT
rs3736228195714424041LRP5umls:C0029456BeFreeThese data suggest that the A1330V variation in the LRP5 gene may affect the pathogenesis of osteoporosis.0.1778854342009LRP51168433827CT
rs3736228184552284041LRP5umls:C0029456BeFreeA non-synonymous SNP in the LRP5 gene was associated with decreased bone mineral density (rs3736228, p=6.3x10(-12) for lumbar spine and p=1.9x10(-4) for femoral neck) and an increased risk of both osteoporotic fractures (odds ratio [OR] 1.3, 95% CI 1.09-1.52, p=0.002) and osteoporosis (OR 1.3, 1.08-1.63, p=0.008).0.1778854342008LRP51168433827CT
rs397507444259815944524MTHFRumls:C0029456BeFreeThe examined SNPs (MTHFR (C677T, and A1298C), TGFβ1 (T869C), and TNFB (A252G)) were tested by genotyping 17 RA patients with OP and 72 RA patients without OP.0.0223653112015MTHFR111794407TG
rs397507444259815947040TGFB1umls:C0029456BeFreeThe examined SNPs (MTHFR (C677T, and A1298C), TGFβ1 (T869C), and TNFB (A252G)) were tested by genotyping 17 RA patients with OP and 72 RA patients without OP.0.2348292312015MTHFR111794407TG
rs4355801184552284982TNFRSF11Bumls:C0029456BeFreeThree SNPs near the TNFRSF11B gene were associated with decreased bone mineral density (top SNP, rs4355801: p=7.6x10(-10) for lumbar spine and p=3.3x10(-8) for femoral neck) and increased risk of osteoporosis (OR 1.2, 95% CI 1.01-1.42, p=0.038).0.1698543422008NA8118911634AG,T
rs4869739244305056711SPTBN1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0026384742015CCDC1706151580667AT
rs48697392443050555094GPATCH1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015CCDC1706151580667AT
rs4869739244305052099ESR1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.1542630432015CCDC1706151580667AT
rs48697392443050522943DKK1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0013572092015CCDC1706151580667AT
rs48697392443050551384WNT16umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0005428842015CCDC1706151580667AT
rs48697392443050584870RSPO3umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015CCDC1706151580667AT
rs48697392443050565084TMEM135umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015CCDC1706151580667AT
rs487004421646926182JAG1umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.0002714422011CCDC1706151580274CT
rs4870044216469264038LRP4umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.0031813582011CCDC1706151580274CT
rs4870044216469262099ESR1umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.1542630432011CCDC1706151580274CT
rs494453205489445906RAP1Aumls:C0029456GWASCATA two-stage meta-analysis of GWAS from 7,633 Caucasian women and 3,657 men, revealed three novel loci associated with osteoporosis-related traits, including chromosome 1p13.2 (RAP1A, p = 3.6x10(-8)), 2q11.2 (TBC1D8), and 18q11.2 (OSBPL1A), and confirmed a previously reported region near TNFRSF11B/OPG gene.0.1226384742010RAP1A1111649500TC
rs5973192443050555094GPATCH1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015TMEM1351187142955AG
rs597319244305052099ESR1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.1542630432015TMEM1351187142955AG
rs5973192443050551384WNT16umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0005428842015TMEM1351187142955AG
rs5973192443050522943DKK1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0013572092015TMEM1351187142955AG
rs597319244305056711SPTBN1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0026384742015TMEM1351187142955AG
rs5973192443050584870RSPO3umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015TMEM1351187142955AG
rs5973192443050565084TMEM135umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015TMEM1351187142955AG
rs6045781790329510982MAPRE2umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007MAPRE21835089476TA
rs6929137216469262099ESR1umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.1542630432011CCDC1706151615542GA
rs6929137216469264038LRP4umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.0031813582011CCDC1706151615542GA
rs692913721646926182JAG1umls:C0029456BeFreeOur study indicates that osteoporosis susceptibility SNPs, such as ESR1 (rs1038304, rs4870044, rs6929137), MHC (rs3130340), low-density lipoprotein receptor-related protein 4 (rs2306033), and jagged1 (rs2273061), might independently and/or in an interactive manner influence ANM and maximal height.0.0002714422011CCDC1706151615542GA
rs7007601790329679670ZCCHC6umls:C0029456GAD[The FHS 100K SNP project offers an unbiased genome-wide strategy to identify new candidate loci and to replicate previously suggested candidate genes for osteoporosis.]0.0023670322007ZCCHC6986319709GT
rs710805217903295390197OR4D10umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007OR4D101159475503GA
rs71760931790329564410KLHL25umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007MIR548AP1585826199GA
rs719988179032951121CHMumls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007CHMX85893361GA
rs720684179032953084NRG1umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007NRG1832200295CT
rs722740120548944114876OSBPL1Aumls:C0029456GAD[A two-stage meta-analysis of GWAS from 7,633 Caucasian women and 3,657 men, revealed three novel loci associated with osteoporosis-related traits, including chromosome 1p13.2 (RAP1A, p = 3.6x10(-8)), 2q11.2 (TBC1D8), and 18q11.2 (OSBPL1A), and confirmed a previously reported region near TNFRSF11B/OPG gene.]0.1226384742010OSBPL1A;LOC1053720251824358694TG
rs722740120548944114876OSBPL1Aumls:C0029456GWASCATA two-stage meta-analysis of GWAS from 7,633 Caucasian women and 3,657 men, revealed three novel loci associated with osteoporosis-related traits, including chromosome 1p13.2 (RAP1A, p = 3.6x10(-8)), 2q11.2 (TBC1D8), and 18q11.2 (OSBPL1A), and confirmed a previously reported region near TNFRSF11B/OPG gene.0.1226384742010OSBPL1A;LOC1053720251824358694TG
rs74832232717427306HPGDSumls:C0029456BeFreeThe results of our study demonstrate the genetic association between detoxifying enzyme GSTM3 and BMD variation, suggesting that the Val224Ile polymorphism and 224Ile-insAGG haplotype could be used for further evaluation of the impact of GSTs gene polymorphisms on osteoporosis, using larger cohorts in searching for osteoporosis risk markers.0.0005428842012GSTM31109737079CT
rs7483223271742947GSTM3umls:C0029456BeFreeThe results of our study demonstrate the genetic association between detoxifying enzyme GSTM3 and BMD variation, suggesting that the Val224Ile polymorphism and 224Ile-insAGG haplotype could be used for further evaluation of the impact of GSTs gene polymorphisms on osteoporosis, using larger cohorts in searching for osteoporosis risk markers.0.0002714422012GSTM31109737079CT
rs760537823303384221981THSD7Aumls:C0029456BeFreeWe previously reported 2 osteoporosis-susceptibility genes--formiminotransferase N-terminal sub-domain containing gene (FONG) and thrombospondin, type 1, domain-containing 7A (THSD7A)--in which we identified two common single-nucleotide polymorphisms, rs7605378 (FONG) and rs12673692 (THSD7A).0.0035386762013FTCDNL1;LOC1053738322199812203AC
rs760537821573128348751FTCDNL1umls:C0029456GWASCATCommon variants in a novel gene, FONG on chromosome 2q33.1 confer risk of osteoporosis in Japanese.0.1202714422011FTCDNL1;LOC1053738322199812203AC
rs76460541849908150650ARHGEF3umls:C0029456GAD[Identification of a role for the ARHGEF3 gene in postmenopausal osteoporosis.]0.0100968882008ARHGEF3356775600AG
rs77410212443050555094GPATCH1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015RSPO3;LOC1053779886127147129AC
rs7741021244305052099ESR1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.1542630432015RSPO3;LOC1053779886127147129AC
rs77410212443050565084TMEM135umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015RSPO3;LOC1053779886127147129AC
rs7741021244305056711SPTBN1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0026384742015RSPO3;LOC1053779886127147129AC
rs77410212443050522943DKK1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0013572092015RSPO3;LOC1053779886127147129AC
rs77410212443050584870RSPO3umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015RSPO3;LOC1053779886127147129AC
rs77410212443050551384WNT16umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0005428842015RSPO3;LOC1053779886127147129AC
rs784288233492252122MECOMumls:C0029456GWASCATMeta-analysis identifies a MECOM gene as a novel predisposing factor of osteoporotic fracture.0.122013MECOM3169253443AG
rs7888911179032951756DMDumls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0096959632007DMDX32543196GT
rs7902708244305056711SPTBN1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0026384742015LOC1053783051052679968GC
rs79027082443050522943DKK1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0013572092015LOC1053783051052679968GC
rs79027082443050584870RSPO3umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015LOC1053783051052679968GC
rs79027082443050551384WNT16umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0005428842015LOC1053783051052679968GC
rs79027082443050555094GPATCH1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015LOC1053783051052679968GC
rs79027082443050565084TMEM135umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.0002714422015LOC1053783051052679968GC
rs7902708244305052099ESR1umls:C0029456BeFreeAlongside SNPs within or near previously identified osteoporosis susceptibility genes including ESR1 (6q25.1: rs4869739, rs3020331, rs2982552), SPTBN1 (2p16.2: rs11898505), RSPO3 (6q22.33: rs7741021), WNT16 (7q31.31: rs2908007), DKK1 (10q21.1: rs7902708) and GPATCH1 (19q13.11: rs10416265), we identified a new locus on chromosome 11q14.2 (rs597319 close to TMEM135, a gene recently linked to osteoblastogenesis and longevity) significantly associated with both BUA and VOS (P < 8.23 × 10(-14)).0.1542630432015LOC1053783051052679968GC
rs809531517903295284274SMIM21umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007NA1875731727AG
rs9307998179032959693RAPGEF2umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007NA4160038858AG
rs9307999179032959693RAPGEF2umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007NA4160038942CT
rs9526581790329553919SLCO1C1umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007SLCO1C11220712367GA
rs97467317903295112399EGLN3umls:C0029456GAD[Longevity and aging traits are associated with SNPs on the Affymetrix 100K GeneChip. None of the associations achieved genome-wide significance. These data generate hypotheses and serve as a resource for replication as more genes and biologic pathways are]0.0023670322007LOC1027249451434011308CT
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:92)
CHR POS SNPID REF ALT ORI_SNPID PMID P_VALUE P_VALUE_TEXT OR/BETA CI95_TEXT GWAS_INITIAL_SAMPLE_SIZE SUB_POPULATION SUPER_POPULATION GWAS_TRAIT HPO_ID HPO_TERM DO_ID DO_TERM MESH_ID MESH_TERM EFO_ID EFO_TERM DOLITE_TERM RISK_ALLELE PUBLICATION_TYPE AA GENE_SYMBOL TYPE REFGENE
1112192122rs494453TCrs494453205489444.00E-08NW, men & womenNANA2,038 European ancestry women; 1,531 European ancestry menEuropean(3569)ALL(3569)EUR(3569)ALL(3569)OsteoporosisHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisD010024OsteoporosisEFOID:0003882osteoporosisOsteoporosisrs494453-CResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
254684557rs11898505AGrs11898505244305054.00E-13(BUA)0.06[0.05-0.08] unit decrease730 East Asian ancestry individuals; 2,380 European ancestry individuals; 11,150 individualsNOPOP(11150)East Asian(730)European(2380)ALL(14260)NOPOP(11150)ASN(730)EUR(2380)ALL(14260)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
254684557rs11898505AGrs11898505244305056.00E-06(VOS)0.05[0.03-0.07] unit decrease2,483 East Asian ancestry individuals; 1,885 European ancestry individuals; 11,146 individualsNOPOP(11146)East Asian(2483)European(1885)ALL(15514)NOPOP(11146)ASN(2483)EUR(1885)ALL(15514)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
285733192rs17792131CTrs17792131205489442.96E-06NANANA2,038 European ancestry women; 1,531 European ancestry menEuropean(3569)ALL(3569)EUR(3569)ALL(3569)OsteoporosisHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisD010024OsteoporosisEFOID:0003882osteoporosisOsteoporosisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
2101668857rs2278729GArs2278729205489441.00E-07NA0.19[NA] unit decrease2,038 European ancestry women; 1,531 European ancestry menEuropean(3569)ALL(3569)EUR(3569)ALL(3569)OsteoporosisHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisD010024OsteoporosisEFOID:0003882osteoporosisOsteoporosisrs2278729-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
2198962243rs7595412GArs7595412187769292.00E-06 5[NA] cm2 increase in hip bone size on women501 women; 499 menNOPOP(1000)ALL(1000)NOPOP(1000)ALL(1000)Hip bone sizeHPOID:0003272Abnormality of the hip boneDOID:11476osteoporosisD010024OsteoporosisNANAOsteoporosisrs7595412-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
2200676926rs7605378ACrs7605378215731282.00E-08NA1.25[1.16-1.35] 190 Japanese ancestry cases; 1,557 Japanese ancestry controlsJapanese(1747)ALL(1747)ASN(1747)ALL(1747)OsteoporosisHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisD010024OsteoporosisEFOID:0003882osteoporosisOsteoporosisNAResearch Support, Non-U.S. Gov'tAFONG
2224274622rs16864755GArs16864755202009534.00E-06Femoral Neck BMD0.24[0.14-0.34] cm3 increase2,073 related womenNOPOP(2073)ALL(2073)NOPOP(2073)ALL(2073)Osteoporosis-related phenotypesHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisD010024OsteoporosisNANAOsteoporosisNAResearch Support, N.I.H., ExtramuralGNA
2235210727rs12151790GArs12151790205489445.00E-07FN BMD, women0.4[NA] g/cm2 increase2,038 European ancestry women; 1,531 European ancestry menEuropean(3569)ALL(3569)EUR(3569)ALL(3569)OsteoporosisHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisD010024OsteoporosisEFOID:0003882osteoporosisOsteoporosisrs12151790-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
3168971231rs784288AGrs784288233492254.00E-08NA1.39[1.24-1.56] 288 Korean ancestry cases; 1,139 Korean ancestry controlsKorean(1427)ALL(1427)ASN(1427)ALL(1427)OsteoporosisHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisD010024OsteoporosisEFOID:0003882osteoporosisOsteoporosisrs784288-AMeta-AnalysisResearch Support, Non-U.S. Gov'tG
5125918148rs13182402AGrs13182402200726032.00E-09NA2.25[1.72-2.94] 350 Han Chinese cases; 350 Han Chinese controlsHan Chinese(700)ALL(700)ASN(700)ALL(700)OsteoporosisHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisD010024OsteoporosisEFOID:0003882osteoporosisOsteoporosisrs13182402-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG,A
687113172rs6919366GTrs6919366220724989.30E-07PC2 - Femoral cross-sectional geometry (female)NANA8481 European ancestry individualsEuropean(8481)ALL(8481)EUR(8481)ALL(8481)Bone mineral density and osteoporosis-related phenotypesHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisNANANANAOsteoporosisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
687136164rs9362320CTrs9362320220724986.00E-07PC2 - Femoral cross-sectional geometry (female)NANA8481 European ancestry individualsEuropean(8481)ALL(8481)EUR(8481)ALL(8481)Bone mineral density and osteoporosis-related phenotypesHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisNANANANAOsteoporosisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
687136247rs9362321CTrs9362321220724984.30E-08PC2 - Femoral cross-sectional geometry (female)NANA8481 European ancestry individualsEuropean(8481)ALL(8481)EUR(8481)ALL(8481)Bone mineral density and osteoporosis-related phenotypesHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisNANANANAOsteoporosisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
687138115rs9351097GTrs9351097220724983.40E-08PC2 - Femoral cross-sectional geometry (female)NANA8481 European ancestry individualsEuropean(8481)ALL(8481)EUR(8481)ALL(8481)Bone mineral density and osteoporosis-related phenotypesHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisNANANANAOsteoporosisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
687140425rs9362322TArs9362322220724989.30E-08PC2 - Femoral cross-sectional geometry (female)NANA8481 European ancestry individualsEuropean(8481)ALL(8481)EUR(8481)ALL(8481)Bone mineral density and osteoporosis-related phenotypesHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisNANANANAOsteoporosisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
687496480rs12665525TCrs12665525220724983.20E-05PC4 - Femoral shaft stabilityNANA8481 European ancestry individualsEuropean(8481)ALL(8481)EUR(8481)ALL(8481)Bone mineral density and osteoporosis-related phenotypesHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisNANANANAOsteoporosisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
687500866rs6911565CArs6911565220724981.10E-05PC4 - Femoral shaft stabilityNANA8481 European ancestry individualsEuropean(8481)ALL(8481)EUR(8481)ALL(8481)Bone mineral density and osteoporosis-related phenotypesHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisNANANANAOsteoporosisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
6127468274rs7741021ACrs7741021244305051.00E-19(VOS)0.06[0.05-0.08] unit increase2,483 East Asian ancestry individuals; 1,885 European ancestry individuals; 11,146 individualsNOPOP(11146)East Asian(2483)European(1885)ALL(15514)NOPOP(11146)ASN(2483)EUR(1885)ALL(15514)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
6127468274rs7741021ACrs7741021244305054.00E-08(BMD-DXA)NANA4,556 European ancestry individualsEuropean(4556)ALL(4556)EUR(4556)ALL(4556)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosisNAMeta-AnalysisResearch Support, Non-U.S. Gov'tA
6127468274rs7741021ACrs7741021244305059.00E-21(BUA)0.06[0.05-0.07] unit increase730 East Asian ancestry individuals; 2,380 European ancestry individuals; 11,150 individualsNOPOP(11150)East Asian(730)European(2380)ALL(14260)NOPOP(11150)ASN(730)EUR(2380)ALL(14260)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
6151901802rs4869739ATrs4869739244305051.93E-09(BUA)0.06[0.05-0.08] unit decrease730 East Asian ancestry individuals; 2,380 European ancestry individuals; 11,150 individualsNOPOP(11150)East Asian(730)European(2380)ALL(14260)NOPOP(11150)ASN(730)EUR(2380)ALL(14260)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
6151901802rs4869739ATrs4869739244305053.00E-18(VOS)0.07[0.06-0.09] unit decrease2,483 East Asian ancestry individuals; 1,885 European ancestry individuals; 11,146 individualsNOPOP(11146)East Asian(2483)European(1885)ALL(15514)NOPOP(11146)ASN(2483)EUR(1885)ALL(15514)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
6152008780rs3020331CTrs3020331244305052.91E-09(BUA)0.05[0.04-0.06] unit increase730 East Asian ancestry individuals; 2,380 European ancestry individuals; 11,150 individualsNOPOP(11150)East Asian(730)European(2380)ALL(14260)NOPOP(11150)ASN(730)EUR(2380)ALL(14260)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
6152008780rs3020331CTrs3020331244305053.00E-09(BUA)0.06[0.04-0.07] unit increase730 East Asian ancestry individuals; 2,380 European ancestry individuals; 11,150 individualsNOPOP(11150)East Asian(730)European(2380)ALL(14260)NOPOP(11150)ASN(730)EUR(2380)ALL(14260)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
6152008780rs3020331CTrs3020331244305056.64E-15(VOS)0.06[0.05-0.08] unit increase2,483 East Asian ancestry individuals; 1,885 European ancestry individuals; 11,146 individualsNOPOP(11146)East Asian(2483)European(1885)ALL(15514)NOPOP(11146)ASN(2483)EUR(1885)ALL(15514)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
6152008780rs3020331CTrs3020331244305057.00E-15(VOS)0.07[0.05-0.08] unit increase2,483 East Asian ancestry individuals; 1,885 European ancestry individuals; 11,146 individualsNOPOP(11146)East Asian(2483)European(1885)ALL(15514)NOPOP(11146)ASN(2483)EUR(1885)ALL(15514)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
6152059563rs2982552GArs2982552244305051.21E-04(BMD-DXA)NANA4,556 European ancestry individualsEuropean(4556)ALL(4556)EUR(4556)ALL(4556)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosisNAMeta-AnalysisResearch Support, Non-U.S. Gov'tC
6152059563rs2982552GArs2982552244305052.00E-10(BUA)0.05[0.04-0.07] unit decrease730 East Asian ancestry individuals; 2,380 European ancestry individuals; 11,150 individualsNOPOP(11150)East Asian(730)European(2380)ALL(14260)NOPOP(11150)ASN(730)EUR(2380)ALL(14260)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
6152059563rs2982552GArs2982552244305057.32E-16(VOS)0.06[0.05-0.07] unit decrease2,483 East Asian ancestry individuals; 1,885 European ancestry individuals; 11,146 individualsNOPOP(11146)East Asian(2483)European(1885)ALL(15514)NOPOP(11146)ASN(2483)EUR(1885)ALL(15514)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
727780476rs11520772ATrs11520772244305052.86E-04(BUA)0.04[0.02-0.06] unit decrease730 East Asian ancestry individuals; 2,380 European ancestry individuals; 11,150 individualsNOPOP(11150)East Asian(730)European(2380)ALL(14260)NOPOP(11150)ASN(730)EUR(2380)ALL(14260)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
738110073rs6974574ATrs6974574244305053.89E-05(VOS)0.06[0.04-0.07] unit increase2,483 East Asian ancestry individuals; 1,885 European ancestry individuals; 11,146 individualsNOPOP(11146)East Asian(2483)European(1885)ALL(15514)NOPOP(11146)ASN(2483)EUR(1885)ALL(15514)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
738110073rs6974574ATrs6974574244305058.25E-05(BUA)0.05[0.03-0.06] unit increase730 East Asian ancestry individuals; 2,380 European ancestry individuals; 11,150 individualsNOPOP(11150)East Asian(730)European(2380)ALL(14260)NOPOP(11150)ASN(730)EUR(2380)ALL(14260)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
776390970rs38664TCrs38664244305051.00E-07(VOS)0.05[0.03-0.07] unit decrease2,483 East Asian ancestry individuals; 1,885 European ancestry individuals; 11,146 individualsNOPOP(11146)East Asian(2483)European(1885)ALL(15514)NOPOP(11146)ASN(2483)EUR(1885)ALL(15514)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
776390970rs38664TCrs38664244305053.25E-04(BUA)0.04[0.02-0.05] unit decrease730 East Asian ancestry individuals; 2,380 European ancestry individuals; 11,150 individualsNOPOP(11150)East Asian(730)European(2380)ALL(14260)NOPOP(11150)ASN(730)EUR(2380)ALL(14260)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
7107973297rs6975557AGrs6975557235932021.56E-04AAM-W, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
7107973297rs6975557AGrs6975557235932025.00E-08AAM-W, EANANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
7107991567rs13230316CGrs13230316235932021.22E-07AAM-W, EANANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
7107991567rs13230316CGrs13230316235932023.67E-04AAM-W, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
7120962164rs2908007AGrs2908007244305051.00E-09(BMD-DXA)0.14[0.09-0.18] unit increase4,556 European ancestry individualsEuropean(4556)ALL(4556)EUR(4556)ALL(4556)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosisrs2908007-GMeta-AnalysisResearch Support, Non-U.S. Gov'tC
7120962164rs2908007AGrs2908007244305052.00E-59(VOS)0.15[0.13-0.17] unit increase2,483 East Asian ancestry individuals; 1,885 European ancestry individuals; 11,146 individualsNOPOP(11146)East Asian(2483)European(1885)ALL(15514)NOPOP(11146)ASN(2483)EUR(1885)ALL(15514)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
7120962164rs2908007AGrs2908007244305054.00E-35(BUA)0.14[0.12-0.16] unit increase730 East Asian ancestry individuals; 2,380 European ancestry individuals; 11,150 individualsNOPOP(11150)East Asian(730)European(2380)ALL(14260)NOPOP(11150)ASN(730)EUR(2380)ALL(14260)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
8119977792rs2062375GCrs2062375205489443.00E-11(LS BMD, women)0.14[NA] g/cm2 increase2,038 European ancestry women; 1,531 European ancestry menEuropean(3569)ALL(3569)EUR(3569)ALL(3569)OsteoporosisHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisD010024OsteoporosisEFOID:0003882osteoporosisOsteoporosisrs2062375-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1054439728rs7902708GCrs7902708244305051.00E-08(BUA)0.07[0.05-0.10] unit increase730 East Asian ancestry individuals; 2,380 European ancestry individuals; 11,150 individualsNOPOP(11150)East Asian(730)European(2380)ALL(14260)NOPOP(11150)ASN(730)EUR(2380)ALL(14260)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
1054439728rs7902708GCrs7902708244305055.00E-15(VOS)0.09[0.07-0.12] unit increase2,483 East Asian ancestry individuals; 1,885 European ancestry individuals; 11,146 individualsNOPOP(11146)East Asian(2483)European(1885)ALL(15514)NOPOP(11146)ASN(2483)EUR(1885)ALL(15514)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
112128309rs4929957GArs4929957235932026.26E-06AAM-CT, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
112138139rs6578985AGrs6578985235932023.00E-06AAM-CT, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
112138139rs6578985AGrs6578985235932026.00E-06AAM-CT, EANANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
112138152rs6578986AGrs6578986235932026.81E-06AAM-CT, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
112141586rs6578987CTrs6578987235932022.96E-06AAM-CT, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1115952294rs11023787CTrs11023787211043665.00E-16NANANA1,000 Caucasian individualsCaucasian(1000)ALL(1000)EUR(1000)ALL(1000)Wrist bone massHPOID:0003019Abnormality of the wristDOID:11476osteoporosisD015519Bone DensityEFOID:0004512bone measurementOsteoporosisrs11023787-TResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1139327959rs12808199GArs12808199205489449.00E-07FN BMD, men0.21[NA] g/cm2 decrease2,038 European ancestry women; 1,531 European ancestry menEuropean(3569)ALL(3569)EUR(3569)ALL(3569)OsteoporosisHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisD010024OsteoporosisEFOID:0003882osteoporosisOsteoporosisrs12808199-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1161570783rs174547TCrs174547229602372.00E-07Males + FemalesNANA825 Chinese ancestry females; 802 Chinese ancestry malesChinese(1627)ALL(1627)ASN(1627)ALL(1627)Comprehensive strength and appendicular lean massHPOID:0005339Abnormality of complement systemDOID:11476osteoporosisD006620Hip FracturesNANAOsteoporosisrs174547-CResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1161571382rs174549GArs174549229602378.00E-07MalesNANA825 Chinese ancestry females; 802 Chinese ancestry malesChinese(1627)ALL(1627)ASN(1627)ALL(1627)Comprehensive strength and appendicular lean massHPOID:0005339Abnormality of complement systemDOID:11476osteoporosisD006620Hip FracturesNANAOsteoporosisrs174549-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1186853997rs597319AGrs597319244305053.05E-04(BMD-DXA)NANA4,556 European ancestry individualsEuropean(4556)ALL(4556)EUR(4556)ALL(4556)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosisNAMeta-AnalysisResearch Support, Non-U.S. Gov'tG
1186853997rs597319AGrs597319244305055.00E-26(VOS)0.07[0.06-0.08] unit decrease2,483 East Asian ancestry individuals; 1,885 European ancestry individuals; 11,146 individualsNOPOP(11146)East Asian(2483)European(1885)ALL(15514)NOPOP(11146)ASN(2483)EUR(1885)ALL(15514)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
1186853997rs597319AGrs597319244305058.00E-14(BUA)0.06[0.04-0.07] unit decrease730 East Asian ancestry individuals; 2,380 European ancestry individuals; 11,150 individualsNOPOP(11150)East Asian(730)European(2380)ALL(14260)NOPOP(11150)ASN(730)EUR(2380)ALL(14260)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
1187226475rs7929583TCrs7929583235932022.89E-05AAM-BR, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1187226475rs7929583TCrs7929583235932024.08E-05AAM-BR, EANANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1187226744rs10898723CTrs10898723235932023.69E-05AAM-BR, EANANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1187226744rs10898723CTrs10898723235932026.12E-05AAM-BR, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1187226744rs10898723CTrs10898723235932029.25E-05AAM-W, EANANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1187226744rs10898723CTrs10898723235932029.56E-05AAM-W, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1187229524rs12146626GArs12146626235932022.72E-05AAM-BR, EANANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1187229524rs12146626GArs12146626235932023.51E-05AAM-BR, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1187229524rs12146626GArs12146626235932024.83E-05AAM-W, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1187229524rs12146626GArs12146626235932025.26E-05AAM-W, EANANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1332485542rs372AGrs372205489445.28E-05NANANA2,038 European ancestry women; 1,531 European ancestry menEuropean(3569)ALL(3569)EUR(3569)ALL(3569)OsteoporosisHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisD010024OsteoporosisEFOID:0003882osteoporosisOsteoporosisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1342951449rs9533090CTrs9533090244305051.40E-05(VOS)0.09[0.06-0.13] unit decrease2,483 East Asian ancestry individuals; 1,885 European ancestry individuals; 11,146 individualsNOPOP(11146)East Asian(2483)European(1885)ALL(15514)NOPOP(11146)ASN(2483)EUR(1885)ALL(15514)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
13110971066rs4773155ACrs4773155220724982.50E-08PC4 - Femoral shaft stability (female)NANA8481 European ancestry individualsEuropean(8481)ALL(8481)EUR(8481)ALL(8481)Bone mineral density and osteoporosis-related phenotypesHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisNANANANAOsteoporosisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
13110982419rs4447275GArs4447275220724985.30E-07PC4 - Femoral shaft stability (female)NANA8481 European ancestry individualsEuropean(8481)ALL(8481)EUR(8481)ALL(8481)Bone mineral density and osteoporosis-related phenotypesHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisNANANANAOsteoporosisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1433273511rs10148694CTrs10148694220724982.40E-05PC2 - Femoral cross-sectional geometryNANA8481 European ancestry individualsEuropean(8481)ALL(8481)EUR(8481)ALL(8481)Bone mineral density and osteoporosis-related phenotypesHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisNANANANAOsteoporosisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1433277871rs7158720CArs7158720220724981.40E-07PC2 - Femoral cross-sectional geometryNANA8481 European ancestry individualsEuropean(8481)ALL(8481)EUR(8481)ALL(8481)Bone mineral density and osteoporosis-related phenotypesHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisNANANANAOsteoporosisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1433277871rs7158720CArs7158720220724984.10E-05PC2 - Femoral cross-sectional geometry (female)NANA8481 European ancestry individualsEuropean(8481)ALL(8481)EUR(8481)ALL(8481)Bone mineral density and osteoporosis-related phenotypesHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisNANANANAOsteoporosisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1686707769rs7188801GArs7188801244305058.00E-06(VOS)0.05[0.03-0.07] unit increase2,483 East Asian ancestry individuals; 1,885 European ancestry individuals; 11,146 individualsNOPOP(11146)East Asian(2483)European(1885)ALL(15514)NOPOP(11146)ASN(2483)EUR(1885)ALL(15514)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
1725607692rs16965654GA,C,Trs16965654205489444.15E-08NANANA2,038 European ancestry women; 1,531 European ancestry menEuropean(3569)ALL(3569)EUR(3569)ALL(3569)OsteoporosisHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisD010024OsteoporosisEFOID:0003882osteoporosisOsteoporosisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1821938658rs7227401TGrs7227401205489444.00E-07NW, men0.17[NA] cm increase2,038 European ancestry women; 1,531 European ancestry menEuropean(3569)ALL(3569)EUR(3569)ALL(3569)OsteoporosisHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisD010024OsteoporosisEFOID:0003882osteoporosisOsteoporosisrs7227401-TResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1867142857rs17184557TArs17184557205489449.00E-07LS BMD, women0.13[NA] g/cm2 increase2,038 European ancestry women; 1,531 European ancestry menEuropean(3569)ALL(3569)EUR(3569)ALL(3569)OsteoporosisHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisD010024OsteoporosisEFOID:0003882osteoporosisOsteoporosisrs17184557-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1929012921rs8113142TCrs8113142235932025.00E-06AAM-CT, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1929035556rs4141232TCrs4141232235932021.02E-05AAM-BR, EANANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1929035556rs4141232TCrs4141232235932022.00E-07AAM-CT, EANANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1929035556rs4141232TCrs4141232235932029.00E-06AAM-BR, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1929035556rs4141232TCrs4141232235932029.31E-06AAM-BR, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1929130465rs4805257CTrs4805257235932021.40E-05AAM-CT, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
1933605300rs10416265AGrs10416265244305052.00E-13(BUA)0.06[0.05-0.08] unit increase730 East Asian ancestry individuals; 2,380 European ancestry individuals; 11,150 individualsNOPOP(11150)East Asian(730)European(2380)ALL(14260)NOPOP(11150)ASN(730)EUR(2380)ALL(14260)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
1933605300rs10416265AGrs10416265244305054.00E-12(VOS)0.06[0.04-0.08] unit increase2,483 East Asian ancestry individuals; 1,885 European ancestry individuals; 11,146 individualsNOPOP(11146)East Asian(2483)European(1885)ALL(15514)NOPOP(11146)ASN(2483)EUR(1885)ALL(15514)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosis
2033703607rs3746429CTrs3746429244305054.35E-04(BMD-DXA)NANA4,556 European ancestry individualsEuropean(4556)ALL(4556)EUR(4556)ALL(4556)Bone properties (heel)HPOID:0000939OsteoporosisDOID:11476osteoporosisNANANANAOsteoporosisNAMeta-AnalysisResearch Support, Non-U.S. Gov'tG
2247198055rs710122GArs710122205489447.33E-06NANANA2,038 European ancestry women; 1,531 European ancestry menEuropean(3569)ALL(3569)EUR(3569)ALL(3569)OsteoporosisHPOID:0005653Moderate generalized osteoporosisDOID:11476osteoporosisD010024OsteoporosisEFOID:0003882osteoporosisOsteoporosisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
X148404622rs4844014ACrs4844014235932023.27E-04AAM-W, EANANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
X148404622rs4844014ACrs4844014235932024.94E-05AAM-W, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
X148477956rs5980450AGrs5980450235932024.60E-05AAM-W, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
X148486762rs7064959GArs7064959235932025.77E-05AAM-W, ChineseNANA1,728 European ancestry individualsEuropean(1728)ALL(1728)EUR(1728)ALL(1728)Femoral neck bone geometry and menarche (age at onset)HPOID:0000939HPOID:0003367OsteoporosisAbnormality of the femoral neckDOID:11476osteoporosisNANAEFOID:0004704age at menopauseOsteoporosisNAResearch Support, N.I.H., Extramural
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:12)
CUI ChemicalName ChemicalID CasRN DiseaseName DiseaseID DirectEvidence PubMedIDs
C0029456arsenic trioxideC0066321327-53-3osteoporosisMESH:D010024marker/mechanism24531206
C0029456caffeineD0021101958/8/2osteoporosisMESH:D010024marker/mechanism19325779
C0029456enalaprilD00465675847-73-3osteoporosisMESH:D010024therapeutic18847324
C0029456teriparatideD01937952232-67-4osteoporosisMESH:D010024therapeutic17317460
C0029456levonorgestrelD016912797-63-7osteoporosisMESH:D010024therapeutic12665316
C0029456pamidronateC01924840391-99-9osteoporosisMESH:D010024therapeutic14964460
C0029456parathyroid hormoneD010281-osteoporosisMESH:D010024therapeutic19463752
C0029456propranololD011433525-66-6osteoporosisMESH:D010024therapeutic24250662
C0029456tenofovirD000068698-osteoporosisMESH:D010024marker/mechanism20923957
C0029456terfenadineD01659350679-08-8osteoporosisMESH:D010024therapeutic15872215
C0029456tretinoinD014212302-79-4osteoporosisMESH:D010024marker/mechanism21835177
C0029456zoledronic acidC088658-osteoporosisMESH:D010024therapeutic17882678
FDA approved drug and dosage information(Total Drugs:4)
DiseaseID Drug_name active_ingredients strength Dosage Form/Route Marketing Status TE code RLD RS
MESH:D010024zometazoledronic acidEQ 4MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasonsINJECTABLE;IV (INFUSION)DiscontinuedNoneYesNo
MESH:D010024zometazoledronic acidEQ 4MG BASE/VIALINJECTABLE; IV (INFUSION)PrescriptionNoneNoNo
MESH:D010024mirenalevonorgestrel52MGINTRAUTERINE DEVICE;INTRAUTERINEPrescriptionNoneYesYes
MESH:D010024levonorgestrellevonorgestrel75MG/IMPLANTIMPLANT;IMPLANTATIONDiscontinuedNoneNoNo
FDA labeling changes(Total Drugs:4)
DiseaseID Pediatric_Labeling_Date Trade_Name Generic_Name_or_Proper_Name Indications Studied Label Changes Summary Product Labeling BPCA(B) PREA(P) BPCA(B) and PREA(P) Pediatric Rule (R) Sponsor Pediatric Exclusivity Granted Date NNPS
MESH:D01002403/20/2008zometazoledronic acidSevere osteogenesis imperfectaZoledronic acid is not indicated for use in children Safety and effectiveness was studied in 152 pediatric patients with severe osteogenesis imperfecta aged 1 - 17 years. At one year, increases in BMD were observed in the zoledronic acid treatment group but the changes did not necessarily correlate with the risk for fracture or the incidence or severity of chronic bone pain Information on PK, clinical study, and AE profileLabelingB---Novartis12/21/2007FALSE'
MESH:D01002403/20/2008zometazoledronic acidSevere osteogenesis imperfectaZoledronic acid is not indicated for use in children Safety and effectiveness was studied in 152 pediatric patients with severe osteogenesis imperfecta aged 1 - 17 years. At one year, increases in BMD were observed in the zoledronic acid treatment group but the changes did not necessarily correlate with the risk for fracture or the incidence or severity of chronic bone pain Information on PK, clinical study, and AE profileLabelingB---Novartis12/21/2007FALSE'
MESH:D0100241/10/2009mirenalevonorgestrel-releasing intrauterine systemTreatment of heavy menstrual bleeding for women using intrauterine contraceptionNew indication for the treatment of heavy menstrual bleeding for women who choose to use intrauterine contraception Use before menarche is not indicatedLabeling-P--Berlex-TRUE'
MESH:D01002410/7/2009plan b one steplevonorgestrelEmergency contraception - OTC in women 17 years and older; RX for women younger than age 17 yearsNew single dose 1.5 mg tablet New dosage regimenLabeling-P--Duramed-FALSE'